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 ABSTRACT 
 
In 1990 the Szostak and Gold groups independently discovered that short pieces of 
RNA can bind to small molecule or biological targets. In 1994 the Joyce group showed that 
DNA, long thought to be solely for information storage, was capable of catalysis. Naturally 
occurring ribozymes were discovered in the 1980s by the Cech group. Since then aptamers, 
which bind targets, and ribozymes or deoxyribozymes, which are catalytically active, have 
become known collectively as “functional nucleic acids.” The common theme of the works 
presented herein involves manipulating functional nucleic acids to further increase our 
understanding of their fundamental properties and to also develop applications for these 
molecules. Chapter 1 is an introduction to the works presented herein. Chapter 2 discusses 
conversion of aptamers into sensors for the determination of enantiomeric ratio, leading to a 
rapid method of detection with high selectivity and portability. Chapters 3, 4, and 5 are tied 
together through the common thread of the 8-17 DNAzyme and involve biochemical and 
biophysical characterization of the 8-17 DNAzyme as well as characterization of a novel red 
Pb2+ species formed upon cleavage of a modified 8-17 DNAzyme.  
Determination of the enantiomeric ratio is important because many monetarily and 
functionally valuable molecules are chiral, such as pharmaceuticals and chiral catalysts. For 
example, Xopenex,® a single enantiomer form of albuterol, has higher efficacy than the 
racemic mixture. There are currently multiple methods for determining the enantiomeric 
ratio, all of which work well, with their own particular caveats. Separations-based methods, 
using a variety of detectors, may require 30 minute runs and often require solvents. NMR and 
fluorescence-based methods are rapid, though the development of a chiral reporter requires 
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many iterative cycles of design and synthesis. Herein, we use the power of aptamers 
generated by in vitro selection to design a fluorescence-based system capable of detecting 
0.1% L-arginine in a solution of D-arginine in five minutes.  
The 8-17 DNAzyme is a RNA-cleaving DNAzyme which is active with divalent 
metal ions, showing the highest activity with Pb2+. The 8-17 DNAzyme has been isolated 
multiple times by different groups and has been the subject of many studies – both 
fundamental and practical. Mutational studies by the Peracchi and Lu groups have shown that 
certain bases in the DNAzyme are highly conserved, though the metal ion binding site is still 
unknown. FRET studies by the Lu group have shown that a folding step is necessary before 
catalysis with either Zn2+ or Mg2+, though Pb2+ does not require a folding step, leading to the 
postulation of a pre-arranged binding site. FRET, however, is a low-resolution technique and 
does not provide information on local folding, or rather changes in the conformation of the 
active site upon metal ion binding. Herein we show that the 8-17 DNAzyme is prearranged 
for Pb2+ as minimal changes in the 1H NMR spectrum are seen upon Pb2+ titration, 
supporting a true “lock-and-key” mode of catalysis.  Addition of Zn2+ or Mg2+, both of which 
induce global folding, results in significant changes in the 1H NMR spectrum. These changes 
are correlated with cleavage activity, indicating local folding accompanies activity. 
Additionally, we show that mutation of the catalytically essential G·T wobble pair to a G-C 
base pair results in perturbation of structure as well as reduced Zn2+ and Pb2+ interaction.  
Chapter 4 demonstrates localization of Pb2+ on the backbone of the 8-17 DNAzyme 
leading us much closer to understanding the Pb2+ binding site and reinforcing the importance 
of the conserved residues in maintaining the hydrogen bonding network, rather than serving 
directly as ligands. Metal ion interactions with the backbone were determined through 
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phosphorothioate mutations. A phosphorothioate is an isostructural mutation consisting of a 
non-bridging backbone oxygen mutated to sulfur. Metal ion affinity changes upon this 
mutation based on Hard Soft Acid Base (HSAB) Theory. Activity with a “hard” metal ion 
such as Mg2+ will be lost if metal ion binding at the phosphorothioate-mutated site is 
catalytically important, as a hard metal ion has much lower affinity for sulfur than oxygen. 
Activity assays were performed which showed that several highly-conserved positions are 
catalytically important for Pb2+ binding, demonstrating interaction of Pb2+ with the backbone 
for the first time. These results were confirmed via 31P NMR. A phosphorothioate mutation 
shifts the backbone peak over 50 ppm downfield and metal ion interaction results in a change 
in the chemical shift. Metal ion titrations were performed and monitored by 31P NMR which 
showed a larger change in chemical shift upon metal ion binding to catalytically important 
backbone residues than control residues. Chapter 5 leads directly out of Chapter 4 in that a 
phosphorothioate mutation at the cleavage site led to a color change upon the addition of 
Pb2+, resulting in a novel red Pb2+-DNA species that is assigned to a Pb2+-2′,3′-cyclic 
phosphorothioate interaction. Cleavage products were characterized by gel-based and 
instrumental methods which showed that a phosphorothioate mutation at the cleavage site did 
not result in a change in cleavage mechanism or cleavage behavior (pH dependence, etc.). 
Small molecule models confirmed that Pb2+ interacted with a pendant phosphorothioate, a 
3′,5′-cyclic phosphorothioate, and a 2′,3′-cyclic phosphorothioate, though only the 2′,3′-
cyclic phosphorothioate-Pb2+ interaction resulted in a species visible to the naked eye. Hg2+ 
was also shown to generate a colored species, and the mutation was extended to a 
phosphorodithioate (where both non-bridging oxygen atoms are substituted) and other 
DNAzyme systems. This system may be useful for detection of cyclic phosphate where a 
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phosphorothioate mutation can be chemically introduced at the cleavage site of an RNA-
cleaving DNAzyme or ribozyme. This system is also the first known soluble red Pb2+ species 
and is highly specific for 2′,3′- over 3′,5′-cyclic phosphorothioates in terms of response. 
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1 Functional DNA 
1.1 Functional DNA 
1.1.1 Biological role and inherent characteristics 
Deoxyribonucleic acid, also known as DNA, is an information storage material 
containing the blueprint of living organisms; the set of instructions for assembly and 
operation of an organism. In contrast ribonucleic acid, RNA, has a more transient (with the 
exception of some viruses that use RNA to store genetic information), though no less 
important, existence resulting in production of proteins or functional RNA. Both DNA and 
RNA are biopolymers composed of nucleosides (themselves composed of a nitrogenous base 
linked to a ribose (RNA) or deoxyribose (DNA) sugar) joined by a phosphate backbone as 
shown in Figure 1.1. The nitrogenous bases are divided into the purines adenine and guanine 
and the pyrimidines cytosine and thymine (uracil in RNA). Adenine forms a base pair with 
thymine and guanine forms a base pair with cytosine all via hydrogen bonding. DNA may 
exist in either a single stranded or double stranded form, double stranded being much more 
common in nature in the form of the double helix. In contrast RNA is usually found in a 
single stranded form which allows it to base pair with itself, forming enzymes with 
complicated structure and dynamics. 
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Figure 1.1 Single stranded DNA illustrating the different bases and phosphate backbone 
connection between the nucleosides. 
1.1.2 Aptamers 
Aptamers are short pieces of RNA or DNA capable of binding selectively to a small 
molecule target or biological material which can be as large as a cancer cell. The first 
aptamers, composed of RNA, were discovered simultaneously by the Gold and Szostak 
labs.1,2 The name was coined by Ellington and Szostak and derived from the Latin root word 
“aptus” or “to fit.”1 Aptamers are obtained via SELEX (Systematic Evolution of Ligands by 
EXponential enrichment), a form of in vitro selection.2 Since the initial discovery numerous 
aptamers have been selected which are capable of binding a wide range of targets with high 
3 
affinity and specificity (potentially sub-nanomolar Kd and million-fold selectivity).3,4 Such 
specificity can extend beyond differentiation of related molecules to chiral molecules. Many 
of these aptamers have been shown to bind a particular enantiomer or other chiral form 
though chiral specificity was not necessarily an intended outcome. 5-10 Examples of aptamers 
with chiral specificity include those against D-adenosine11 (the normal form in RNA and 
DNA) and L-arginine7 (the predominant enantiomer and one of the 20 essential amino acids). 
These targets are shown in Figure 1.2 and Figure 1.3. 
 
Figure 1.2 L- and D-adenosine, left to right. 
 
 
Figure 1.3 L- and D-arginine, left to right. 
Considering that DNA and RNA are composed of nucleotides with inherent chirality 
(D- form), and DNA also commonly forms a chiral double helix, it is not very surprising that 
such chiral specificity towards a given substrate can result from in vitro selection. Synthesis 
of L-DNA or L-RNA (the mirror image of natural or D-DNA) results in a nuclease-resistant 
biopolymer with materials12 and pharmaceutical applications. Noxxon Pharma AG is in the 
process of commercializing L-RNA aptamers for pharmaceutical applications and is making 
progress with completion of Phase I trials for two different targets. Their approach involves 
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spiegelmers13,14 which are obtained by in vitro selection. The object of selection is the non-
target enantiomer (the mirror image of the desired target). Once an aptamer with high affinity 
is obtained, a mirror image aptamer is synthesized from L-RNA. As L-RNA is a mirror 
image of D-RNA, L-RNA will have affinity for the mirror image target enantiomer, and the 
aptamer will be nuclease-resistant, allowing in vivo applications. The same concept may be 
extended to DNA selection. 
1.1.3  Ribozymes and deoxyribozymes 
Naturally occurring ribozymes have been known for almost three decades15 and the 
development of synthetic deoxyribozymes (none have been discovered in nature) took place 
a decade later.16 Ribozymes and deoxyribozymes (also known as DNA enzymes or 
DNAzymes) are catalytic nucleic acid molecules capable of performing a variety of reactions 
and are obtained through in vitro selection (ribozymes may also be naturally occurring).17-20 
Analogous to protein enzymes a cofactor may be required for catalysis and metal ions often 
serve such a role.18,21,20 Though DNAzymes are capable of many reactions the focus of this 
work is on RNA-cleaving DNAzymes, the first type selected.16 RNA cleaving DNAzymes 
active with a variety of metal ions have been selected including Mg2+,22,23 Zn2+,24,25 UO22+,26 
Ca2+,27 Co2+,28 Cd2+/Mn2+/Ni2+,29  and Hg2+/As5+.30 There is also one example of a DNA-
cleaving DNAzyme utilizing Cu2+ 31 and a DNAzyme catalyzing sequence-specific 
hydrolysis of DNA utilizing Mn2+ and Zn2+.32  
1.1.4 In vitro selection 
Nucleic acids that have functions beyond information storage, such as target binding 
(aptamers) and catalysis (ribozymes/deoxyribozymes), have been termed “functional nucleic 
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acids.”15,1,16,33 Much of the following discussion applies to functional RNA as well as 
functional DNA, though the discussion is framed primarily in terms of DNA in fitting with 
the scope of this body of work.  
Though enzymes composed of DNA have not been found in nature, in vitro selection 
has revealed that DNA can form complicated secondary structures which impart catalytic 
ability.16,17 Though the particular sequences and structures used in a given selection may be 
substantially different from one another (e.g. aptamer vs. deoxyribozyme selection) the same 
basic process applies as shown in Figure 1.4 
 
Figure 1.4 General schematic of the in vitro selection process, beginning with a random pool 
of 1014+ individual sequences and through repeated cycles of selection and 
amplification/mutation a target sequence is obtained. 
 
Selection of an aptamer entails incubation of the target with a random pool of DNA. 
The target may either be free in solution or bound to a column. In column-based selection the 
target is covalently bound to the column. The DNA pool is incubated with the column 
followed by washing steps to remove sequences that are unbound or weakly bound. The 
bound sequences are released by addition of free target, by heating, or by a combination of 
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both. The eluted sequences are then amplified by polymerase chain reaction (PCR) and may 
also undergo mutation during amplification. Rounds of selection are repeated with increasing 
stringency, e.g. lower concentrations of target, shorter incubation times, increased washes, 
etc. Eventually the pool is cloned and sequenced. Sequences appearing multiple times are 
compared and an aptamer is obtained following truncation, optimization and comparison of 
target affinity amongst clones.  
The general scheme for RNA-cleaving DNAzyme selection is similar. The random 
pool is incubated with a metal ion and cleaved vs. uncleaved sequences may be separated by 
denaturing polyacrylamide gel electrophoresis (PAGE). Cleaved sequences are then 
amplified and subjected to further rounds of selection. Negative selection may be used as a 
tool to decrease affinity for non-target metal ions. The pool is incubated with a metal ion 
soup and cleaved sequences are removed, minimizing non-specific cleavage. Finally, 
cloning, sequencing, and optimization take place as for aptamers. 
The random pool used in selection contains 1014 to 1015 unique strands. The number 
of random sequences are determined by 4n where n is the length of the random region and 4 
represents the four possible bases at each position (A,G,C, or T). Increasing size of the 
random region rapidly leads to a physically limited pool as working with DNA at the 
kilogram level is simply not practical. Therefore, as a general rule much less than 1% of the 
sequence space will be sampled due to these physical limitations. Longer sequences may 
allow for more complex structures, though shorter sequences ensure more thorough sampling 
of the sequence space. As evidenced by the number and variety of aptamers and DNAzymes 
selected,3 many different approaches can yield a positive result. 
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From the point of view of Inorganic Chemistry, DNA possesses a very large set of 
potential ligands which are capable of adopting numerous geometries and providing both 
nitrogen and oxygen donors to metal ions while also allowing for hydrogen bonding and π-
stacking interactions with small molecules. Though DNA possesses only four building 
blocks, compared to the 20 essential amino acids, the ability to adopt a wide range of 
structures and interact with cofactors help overcome any lack of diversity. Additional 
functional groups may be added via chemical synthesis, further enhancing the available 
ligand set.34 The process of in vitro selection allows researchers to sample a wide range of 
geometries and ligands, allowing great selectivity for a given target without repeated design 
cycles. Eventually, structure determination of DNAzymes may allow insight into an optimal 
ligand set for a given metal ion, keeping in mind the conditions under which the selection 
was accomplished. 
1.1.5 The 8-17 deoxyribozyme 
The 8-17 DNAzyme, so called because it was the 17th clone from the 8th round of 
selection,22 was isolated through in vitro selection under various conditions by several 
groups.27,22,24,35,36 The 8-17 motif even appeared in one selection in the absence of metal-ion 
cofactors.37 None of these selections contained Pb2+, though Pb2+ is the most active metal ion 
cofactor.38 The secondary structure of the 8-17 DNAzyme, more specifically the 17E 
variant,24 is shown below in Figure 1.5. The catalytic core of 8-17 is highly conserved, 
though some variance is tolerated.38,39 
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Figure 1.5 Secondary structure of the 8-17 DNAzyme. 
 
A related DNAzyme, the 10-23 DNAzyme, was obtained in the same selection as 8-
17 and it has been postulated that the 10-23 DNAzyme is a special variant of 8-17. 22,40 The 
8-17 DNAzyme is of interest for several reasons including reoccurrence. Is there a special 
stability that results in reoccurrence? In addition, the 8-17 DNAzyme is most active with 
Pb2+, though is also active with Zn2+ and Mg2+.38 The RNA-based leadzyme and the GR-5 
DNAzyme are much more specific for Pb2+.41,42,16,43 What allows accommodation of activity 
with different metal ions? Conversion of 8-17 into a sensor for Pb2+  started a large chain of 
practical applications,44 though behavior of the system is still poorly understood. Greater 
understanding of behavior may lead towards improved sensor design and understanding of 
metal ion binding in biological systems. 
1.2 Sensing applications 
1.2.1 Signal output 
A good sensor must be both sensitive and selective. Sensitive in order to detect small 
quantities of target and selective to do so within a complicated matrix such as surface water 
or blood, where many different interfering species may be present. In order for sensing to 
take place, three general steps are necessary as shown in Figure 1.6. First, the analyte of 
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interest must be recognized as selectively as possible to minimize false positives. Second, a 
transduction step is necessary to convert the recognition event into some output that can be 
measured. Finally, the output must be read either visually or by an instrumental technique. 
 
Figure 1.6 General recognition, transduction, and output scheme for sensing. 
Classical methods for detection of small molecules may involve separation techniques 
such as gas chromatography (GC), high pressure liquid chromatography (HPLC), or capillary 
electrophoresis (CE) with confirmation by mass spectrometry (MS) or nuclear magnetic 
resonance (NMR). All of these steps may be relatively time consuming and of limited 
portability. Fluorescence- and absorbance-based are portable alternatives; though design of 
synthetic small-molecule receptors requires repeated design and synthesis cycles. 
1.2.2 Aptamer-based sensing 
The selectivity and sensitivity of aptamers, with KD values often at the nM level,4 
provides ripe opportunities for sensing and numerous sensors based on aptamers have been 
reported45-58,33,59 Looking back to the general scheme of sensing, an output of some sort is 
necessary for sensing to take place. The aptamer itself serves only as the recognition element. 
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One method of signal transduction and output is through use of a structure switching 
signaling aptamer as described for adenosine by Nutiu, et al. 11 This method provides a 
fluorescent output readable in either a bench top or handheld instrument and uses only 
nanomolar concentrations of DNA due to the sensitivity obtainable by fluorescence 
detection. The general scheme is shown in Figure 1.7. 
 
Figure 1.7 General scheme for a structure switching signaling aptamer. “F” indicates a 
fluorophore and “Q” indicates a quencher. Target binding by the aptamer strand results in 
base pair dissociation between the aptamer and quencher strands, release of the quencher 
strand, and an increased fluorescence signal. 
 
The longest strand is composed of a truncated aptamer sequence with an extension on 
the 5′ end which is complementary to a separate “fluorophore strand” and partially 
complementary to the “quencher strand.” All strands are hybridized together by annealing, 
placing the fluorophore in close proximity to the quencher leading to quenched fluorescence 
with minimal background. Upon target binding the base pairs between the quencher strand 
and aptamer are disrupted, causing release of the quencher strand. Another method of signal 
generation is the disaggregation of gold nanoparticles, transforming from blue aggregates to 
red when free in solution, such as in the detection of adenosine and cocaine.60 Such a system 
is similar in the basic design to the structure switching system described above. The aptamer 
strand is extended on the 5′ end and two smaller strands are also present, though instead of a 
fluorophore and quencher the strands are conjugated to gold nanoparticles. Upon target 
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binding one strand is released resulting in a shift from blue to red. The signal may be 
quantitated by UV-Vis or compared visually. 
1.2.3 Deoxyribozyme-based sensing 
DNAzymes have been converted into sensitive and selective sensors of various 
designs58,33,61 and used in numerous applications other than sensing.62 Initially, the 8-17 
DNAzyme was converted into a fluorescence-based sensor by attaching a fluorophore to the 
5′ end of the substrate strand and a quencher to the 3′ end. Release of the cleaved substrate 
resulted in a fluorescence increase.44 This system was then extended by inclusion of an 
intramolecular quencher.63 Since then electrochemical64 and electrochemiluminescence65 
detection of Pb2+ has also been developed and DNAzyme-based sensors have been extended 
to a microarray format.66 A temperature-independent sensor has been developed by 
introducing base mismatches in the double stranded releasing arm, controlling the release of 
the substrate strand.67 Colorimetric detection using assembly and disassembly of gold 
nanoparticles has also become popular.68 The GR-5 DNAzyme has been converted into a 
sensor for Pb2+ with greater selectivity than 8-17-based sensors.43 Catalytic beacon sensors 
for Cu2+ and UO22+ have also been reported.26,69 These examples are by no means 
comprehensive and serve to illustrate the breadth of detection methods available. 
1.3 Characterization of deoxyribozymes 
1.3.1 Biochemical characterization 
Though deoxyribozymes have demonstrated utility as sensors, the understanding of 
their metal ion binding behavior is still incomplete. The 8-17 DNAzyme in particular has 
been thoroughly studied by biochemical methods.38,70-73,40  Several works, through selective 
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mutation and truncation, have led to an understanding of the conserved sequence.38,39 
Peracchi and coworkers studied the similarities between the Mg5 and 8-17 variants including 
Ca2+ specificity and kinetic features.74,75 Several studies have focused on the diversity of 8-
17, studying the dinucleotide junction cleavage,35,71 cleavage using only guanosine and 
cytidine deoxyribonucleotides,76 and appearance of the 8-17 motif in relation to excess 
sequence elements.77 Complementing the mutational studies by focusing on metal ion 
binding as opposed to conserved bases, terbium luminescence spectroscopy has indicated that 
Pb2+ and Zn2+ bind in different manners, based on competition with Tb3+.78 Activity with 
high concentrations of monovalent ions and Z-DNA formation in the presence of Zn2+ and 
Mg2+, but not Pb2+,  have been reported.79 Recently the substitution of abasic nucleotides and 
C3 spacers have indicated that 8-17 can tolerate more perturbation than originally thought 
while maintaining activity, indicating a great deal of plasticity.40 
1.3.2 Biophysical characterization 
The 8-17 DNAzyme has also been studied by biophysical methods.80,81,78,79,82 
Electron hole flow has yielded information about base stacking and solvent exposure by 
monitoring damaged regions due to electron hole flow (interrupted transfer results in 
damage, indicating a change in conformation).83 Förster or Fluorescence Resonance Energy 
Transfer (FRET) studies,84,80,50,81,82 have revealed global folding in the presence of Zn2+ and 
Mg2+, but not in the presence of Pb2+, which is the most active metal ion. A recent study 
investigated the effect of the cleavage site on global folding.82 Photocrosslinking studies have 
given the best impression to date of the tertiary structure of the 8-17 DNAzyme and have 
provided evidence for local folding. In short, modified oligonucleotides are incorporated into 
the enzyme/substrate at different positions, crosslinking is initiation by hν, and products are 
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analyzed by PAGE.70,72 A recent work has shown crosslinking with the scissile site indicating 
asymmetric positioning of C13 and the importance of C3.73 
These results suggests that the selectivity for Pb2+ over other metal ions arises from a 
pre-organized structure capable of binding Pb2+ with minimal or no structural change, similar 
to the lock-and-key mode in protein enzyme catalysis. FRET, however, is a low-resolution 
spectroscopic method and can only probe global folding; subtle local structural changes may 
not be detectable. Therefore, a higher resolution technique is needed to see if this DNAzyme 
is truly operating in a lock-and-key mode with Pb2+. It should also be noted that the 8-17 
DNAzyme possesses a great deal of plasticity, accepting many different mutations while 
maintaining some level of activity. C12, G14, and A6 are known to be essential for activity, 
though do not necessarily participate in metal ion binding, but rather formation of a hydrogen 
bonding network. The ligands to the metal cofactors remain unknown. 
1.4 Research focus 
The research works presented are united under the heading of “functional DNA,” 
though the scope and methods are broad. Chapter 2 discusses conversion of aptamers into 
sensors for the determination of enantiomeric ratio, leading to a rapid method of detection 
with high selectivity and portability. Many high-value molecules are chiral, such as 
pharmaceuticals and chiral catalysis, and enantiomeric purity is very important. For example, 
Xopenex,® a single enantiomer from of albuterol, has higher efficacy than the racemic 
mixture. Separations-based methods require long runs, on the order of 15 minutes. 
Fluorescence-based methods are rapid, though design of a chiral fluorescent reporter requires 
many cycles of synthesis. Herein, we use the power of aptamers generated by in vitro 
selection to design a fluorescence-based system capable of detecting 0.1% L-arginine in a 
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solution of D-arginine.85 Chapters 3, 4, and 5 are tied together through the common thread 
of the 8-17 DNAzyme. Chapter 3 covers the 1H NMR study of the 8-17 DNAzyme and 
contributes to our understanding of the local folding behavior in the presence of various 
divalent metal ions. FRET studies have shown that a folding step is necessary before 
catalysis with either Zn2+ or Mg2+, though Pb2+ does not require a folding step, leading to the 
postulation of a pre-arranged binding site.80,50 However, FRET is a low-resolution technique 
and does not provide information on local folding, or changes in conformation of the active 
site. Herein we show that the 8-17 DNAzyme is prearranged for Pb2+, following a true “lock-
and-key” mode of catalysis. Additionally, we show that mutation of the catalytically essential 
G·T wobble pair to a G-C base pair results in perturbation of structure as well as reduced 
Zn2+ and Pb2+ interaction.  
Chapter 4 discusses very exciting results, demonstrating localization of Pb2+ on the 
backbone of the 8-17 DNAzyme leading us much closer understanding of the Pb2+ binding 
site and reinforcing the importance of the conserved residues in maintaining the hydrogen 
bonding network rather than serving as ligands. Despite many studies on the 8-17 DNAzyme, 
the metal ion binding site is still unknown. Interactions were determined through 
phosphorothioate mutation. A phosphorothioate is an isostructural mutation consisting of a 
non-bridging backbone oxygen mutated to sulfur. Metal ion affinity changes upon this 
mutation based on Hard Soft Acid Base Theory86 and activity with the “hard” Mg2+ will be 
lost if metal ion binding at the phosphorothioate mutated site is catalytically important, as 
Mg2+ has much lower affinity for sulfur than oxygen. Activity assays were performed which 
showed that several highly-conserved positions are catalytically important for Pb2+ binding, 
demonstrating interaction of Pb2+ with the backbone for the first time. These results were 
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confirmed via 31P NMR. A phosphorothioate mutation shifts the backbone peak over 50 ppm 
downfield and metal ion interaction results in a change in the chemical shift. Pb2+ titrations 
were performed and monitored by 31P NMR which showed a larger change in chemical shift 
upon metal ion binding to catalytically important backbone residues than control 
phosphorothioate residues. Chapter 5 leads directly out of Chapter 4 in that a 
phosphorothioate mutation at the cleavage site led to a color change upon the addition of 
Pb2+ giving a novel red Pb2+-DNA species that is assigned to a Pb2+-2′,3′-cyclic 
phosphorothioate interaction. Cleavage products were characterized by PAGE, UV-Vis, 
MALDI-MS, ICP and other methods which showed that a phosphorothioate mutation at the 
cleavage site did not result in a change in cleavage mechanism or cleavage behavior (pH 
dependence, etc). Small molecule models confirmed that Pb2+ interacted with a pendant 
phosphorothioate, a 3′,5′-cyclic phosphorothioate, and a 2′,3′-cyclic phosphorothioate, 
though only the 2′,3′-cyclic phosphorothioate-Pb2+ interaction resulted in a species visible to 
the naked eye. Hg2+ was also shown to generate a colored species, and the mutation was 
extended to a phosphorodithioate (both non-bridging oxygen atoms are substituted) and other 
DNAzyme systems. This system may be useful for detection of cyclic phosphate where a 
phosphorothioate mutation can be chemically introduced at the cleavage site of an RNA-
cleaving DNAzyme or ribozyme. This system is also the first known soluble red Pb2+ species 
and is highly specific for 2′,3′- over 3′,5′-cyclic phosphorothioates. 
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2 Rapid Determination of Enantiomeric Ratio using Fluorescent DNA or 
RNA Aptamers 
Notes and acknowledgements: The authors wish to thank Kyle Miner for helpful 
discussions on data fitting and the U.S. Department of Energy (DOE grant DE-FG02-
08ER64568) for financial support. This chapter is the basis for a published manuscript: Null, 
E. L.; Lu, Y. “Rapid Determination of Enantiomeric Ratio using Fluorescent DNA or RNA 
Aptamers” Analyst, 2010, 135, 419. 
2.1 Introduction 
Asymmetric catalysis is an important process in modern chemistry and biology, as it 
can generate a number of valuable products such as chiral pharmaceutical drugs.1 A critical 
step in asymmetric catalyst discovery and characterization is the determination of the 
reaction product’s enantiomeric ratio (ER). Instrumental techniques such as chiral gas 
chromatography (GC) and chiral high pressure liquid chromatography (HPLC) can directly 
determine the ER. Nuclear magnetic resonance (NMR) is another option, although chiral 
solvents and chiral additives such as shift reagents may be necessary.2 Even though chiral 
GC, HPLC, and NMR are very accurate and thus have become workhorses of synthetic 
laboratories, they are not easily adapted to high throughput analysis due to high sample 
handling requirements; this has led to slow and costly analysis. 
 One effective way to improve the efficiency of sample analysis is to avoid separation 
steps and use optical methods to directly and simultaneously analyze thousands of samples 
using arrays.3,4 Many of the current optical methods, however, require the design and 
synthesis of chiral receptors through trial-and-error processes, as well as the asymmetric 
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synthesis of optically active compounds. In addition, the selectivity of de novo designed 
systems may not be easily optimized due to the difficulties of testing a large number of 
designs. Therefore, a more general method for the optical determination of enantiomeric ratio 
is needed. 
 Systematic Evolution of Ligands by Exponential Enrichment (SELEX) has been 
established as a general method to obtain DNA or RNA aptamers that bind a wide range of 
molecules.5-8 DNA and RNA are naturally chiral and it has been shown that these aptamers 
can discriminate between optical isomers.9-13 Due to this property, aptamers have been used 
for chiral separations by HPLC and capillary electrophoresis,14-18 and for asymmetric 
catalysis.19,20 Therefore aptamers are an ideal platform for the optical determination of ER. 
Although a number of aptamer-based sensors have been reported in the literature,21-36 only 
recently has a chiral fluorescence sensing application been demonstrated.37 Herein we present 
a general platform for the simple, low-cost, and high-throughput detection and quantification 
of the chirality of a broad range of molecules by adopting a structure-switching, aptamer-
based fluorescent sensing method.38 As a result, we have extended the best reported detection 
of the minor enantiomer from the 1% to the 0.1% level through calibration. 
2.2 Materials and methods 
2.2.1 DNA and reagents 
Fluorophore- (FAM) and quencher- (DABCYL) labeled strands were synthesized and 
HPLC-purified by Integrated DNA Technologies, Inc. (Coralville, IA). The adenosine 
aptamer was synthesized by Integrated DNA Technologies, Inc. and gel-purified in house. 
The chimeric DNA/RNA arginine aptamer was synthesized and purified via RNase-free 
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PAGE by TriLink BioTechnologies (San Diego, CA). L-arginine and D-arginine were 
purchased from Chem-Impex International (Wood Dale, IL). D-adenosine was purchased 
from Sigma-Aldrich. L-adenosine was purchased from ChemGenes Corporation 
(Wilmington, MA). ACS reagent-grade buffers and reagents were from either Fisher 
Scientific or Sigma-Aldrich. All solutions were made using water purified by a Millipore 
system. 
2.2.2 Sensor preparation and fluorescence measurements 
Fluorescence-based sensor solutions were mixed in the appropriate buffer using 40 
nM fluorophore strand, 80 nM aptamer strand, and 120 nM quencher strand.  The adenosine 
sensor buffer was 20 mM Tris·HCl at pH 8.3 containing 300 mM NaCl, and 5 mM MgCl2. 
The arginine sensor buffer contained 20 mM Bis-tris at pH 7.0, 50 mM NaCl, and 5 mM 
MgCl2. Solutions were allowed to incubate for a minimum of 30 min. at room temperature to 
anneal.  The target was added 30 seconds after the start of data collection.  Adenosine 
solutions were heated to aid in dissolution. Fluorescence experiments were carried out on a 
Fluromax-3 (HORIBA Jobin Yvon, Inc., Edison, NJ). The temperature of the sample was 
held constant at 25 °C using a temperature controller interfaced with the fluorimeter (LSI-
3751 from Wavelength Electronics). The excitation wavelength was 490 nm and emission 
was monitored at 520 nm. 
2.3 Results and discussion 
As a proof-of-concept, the structure-switching signaling DNA aptamer for 
adenosine38 was tested for its ability to discriminate between D- and L-adenosine. As 
described previously,38 the general design consists of three DNA segments (see Figure 1): An 
aptamer with a nucleotide extension at the 5-end (called the aptamer strand) that can 
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hybridize to another DNA with a fluorophore (FAM) label at its 5-end (called the 
fluorophore strand), and a the third DNA strand which is labelled with a quencher 
(DABCYL) at the 3-end (called the quencher strand). Sequences of the adenosine and 
arginine sensor components are shown in Figure 2.1.  
 
Figure 2.1 Sequences and design of structure switching DNA and RNA aptamers for the 
fluorescent determination of the enantiomeric ratio of adenosine and arginine, respectively. 
(a) Sequences of the three components of structure-switching DNA aptamer for adenosine 
(aptamer sequence shown in grey);  (b) Sequences of the three components of the structure-
switching RNA aptamer for arginine (aptamer sequence shown in grey);  (c) Schematic 
illustration of the structure-switching method for both DNA and RNA aptamers shown in a 
and b. F and Q represents the FAM fluorophore and DABCYL quencher, respectively. 
As illustrated in Figure 2.1c, in the absence of the target, the fluorescence from FAM 
is suppressed by DABCYL through hybridization. In the presence of the target, on the other 
hand, the binding of the target by the aptamer weakened the hybridization between the 
aptamer and quencher strands because of a decrease in the number of base pairs. Thus the 
quencher strand was released under ambient conditions, increasing the fluorescence signal. 
At pH 8.3 in 20 mM Tris·HCl buffer containing 300 mM NaCl and 5 mM MgCl2, the 
addition of 1 mM D-adenosine to the DNA aptamers enhanced the normalized fluorescent 
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intensity by ~9, due to structure-switching of the adenosine aptamer. In contrast, 1 mM L-
adenosine gave a fluorescence increase of ~1/3 that of D-adenosine (Figure 2.2a), indicating 
that the fluorescent adenosine sensor can be used to discriminate between different optical 
isomers of adenosine.  The relative dissociation constants were determined to be 0.7 mM for 
D-adenosine and 2.6 mM for L-adenosine as determined by the ligand concentration at half 
of the maximal fluorescence increase. 
 
Figure 2.2 Fluorescent response of the adenosine system to (a) 1 mM D- and 1 mM L-
adenosine upon addition of target at 30 seconds, (b) varying concentrations of D- and L-
adenosine, and (c) percentages of D-adenosine at a total adenosine concentration of 1 mM, 
270 seconds after target addition. D- and L-adenosine samples in (a) and (b) were run 
separately. Samples in (c) are mixtures of D- and L- adenosine. 
 To find out if the fluorescent signal can be used to quantitatively determine the 
percentage of D-adenosine in a mixture of D- and L-adenosine, the normalized fluorescent 
intensity at 520 nm was plotted against known D-adenosine percentages while keeping the 
total concentration of the two optical isomers constant. At 1 mM adenosine, the response to 
both D- and L-adenosine independently is within the linear range and provides a high signal 
without reaching a maximum (Figure 2.2b); therefore, 1 mM total adenosine was chosen for 
the chiral determination. A linear response was obtained between 0% and 100% as shown in 
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Figure 2.2c, suggesting that the fluorescent DNA sensor can be used for chiral quantification. 
The size of the error bars in Figure 2.1c can be partially attributed to the low solubility of the 
adenosine stock solution. 
 After the proof-of-concept experiment using the adenosine aptamer, we wished to 
apply the concept to a RNA aptamer and to the determination of a chiral amino acid, due to 
their ubiquity in biological systems. We chose a RNA aptamer for L-arginine due to its high 
selectivity over D-arginine.11 The structure-switching design scheme shown in Figure 1c was 
again used and the specific sequences are shown in Figure 2.1b. 
 While the fluorophore strand remained the same, the quencher strand sequence was 
changed to ensure hybridization to the aptamer strand. The fluorophore strand sequence was 
kept the same to ensure continuity and to minimize cost. The arginine aptamer was truncated 
on both ends to remove the primer regions and then extended on the 5′ end with the same 
extension sequence that was used in the adenosine system. The ratio of the aptamer strand to 
the fluorophore and quencher strand was maintained at the level used for the adenosine 
system.  
 A range of buffers at different concentrations, pH, and Na+ concentrations were 
tested. Unlike the adenosine system, the optimal buffer system for arginine detection was 
found to be 20 mM Bis-Tris pH 7.0 containing 50 mM NaCl and 5 mM MgCl2. Shorter 
quencher strands were tested, although the response was not as high as for the strand shown 
above. Longer strands were not tested as very low Na+ concentrations would be necessary to 
destabilize their hybridization, and such low Na+ concentrations could interfere with target 
binding. 
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 The response to D-arginine reached a maximum three-fold increase whereas the 
response to L-arginine reached a maximum five-fold increase at ~10 mM arginine as shown 
in Figure 3a. The difference in response between the enantiomers was sufficient to allow for 
detection in a mixture. Concentrations of 2 mM and 10 mM total arginine were used to test 
varying percentages of L-arginine and the resulting data is shown in Figures 2.3b, 2.4 and 
2.5. 
 
Figure 2.3 Response of the arginine structure-switching system to (a) varying concentrations 
of L- and D-arginine and (b) percent L-arginine at a total arginine concentration of 10 mM. 
 Unlike the linear fluorescent response of the adenosine system to % D-adenosine 
(Figure 2.2c), the fluorescent response of the arginine sensor to % L-arginine at 10 mM total 
arginine first increased rapidly between 0-10 %, with one relatively steep slope and then 
increased less dramatically between 10-20 %. The rapid signal increase between 0 % and 10 
% allowed for greater sensitivity. The fluorescence response of the system in the absence of 
L-arginine (10 mM D-arginine) was 2.64±0.02, whereas the normalized fluorescence 
response to 0.1% L-arginine at 10 mM total arginine was 3.02±0.01, allowing detection at the 
0.1 % or 0.1:99.9 (L:D) ER level. Such high chiral discrimination was for the (L:D) ratio, not 
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the (D:L) ratio because of the greater sensitivity towards L-arginine over D-arginine. By 
lowering the total concentration of arginine from 10 mM to 2 mM, the overall sensitivity 
towards L-arginine can be reduced, resulting in a larger detection range as shown in Figure 5. 
 The relative dissociation constants were determined to be 3.4 mM for L-arginine and 
5.0 mM for D-arginine. To allow ER to be determined from a plot accounting for the relative 
dissociation constants, the normalized fluorescence intensity was plotted against θL/θD as 
defined in Equation 2.1. 
      )(][][)(][][ DKDDLKLL ddDL   
Equation 2.1 Theta ratio defined in relation to generic D and L. 
Theta as derived from the Kd equation is equivalent to the number of ligand binding 
sites on the aptamer strand that are occupied by the target. The binding of target will release 
the quencher strand. Therefore, the theta ratio is the ratio of the release of the quencher due 
to L- over the release of the quencher due to D-; it is also equivalent to the signal due to L- 
over the signal due to D- 
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Figure 2.4 Response to a range of theta arginine ratios at 10 mM total arginine with 
asymptotic fitting. 
The fitting procedure was applied to the data for 10 mM total arginine (see Figure 
2.4) and 2 mM total arginine (Figure 2.5). The difference in Kd between enantiomers is the 
reason for the noted enantioselectivity and the plot of F/F0 vs θL/θD yields a plot analogous to 
that of F/F0 versus % L-arginine. 
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Figure 2.5 Response to 2 mM total arginine versus varying percentages of L-arginine and the 
corresponding theta ratio. 
 As shown in Figure 5, the relationship between % L-arginine and θL/θD is not linear 
due to the different Kd values for L- and D-arginine. By using the apparent Kd values and the 
known total concentration of arginine, one can calculate the ER. 
 The calibration curves given are for 10 mM and 2 mM total arginine.  If one desires 
to use any other concentration of arginine, a separate calibration curve must be fitted; this is 
quickly accomplished using a program such as OrginPro 8. The resulting asymptotic 
equations are shown in Equation 2.2 and Equation 2.3 for 10 mM total arginine and 2 mM 
total arginine, respectively. The asymptotic fit for 10 mM total arginine is shown in Figure 
2.4. 
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Equation 2.2 Asymptotic equation for 10 mM total arginine. 
D
L
F
F )147.0(*18.141.2
0

 
Equation 2.3 Asymptotic equation for 2 mM total arginine. 
 In order to show that the curve-fitting procedure is sensitive to small variations in the 
data over six months, the curve was regenerated and data points from concentrations not used 
to generate the curve were checked against the curve. The resulting equation is shown in 
Equation 2.4. The calculated % L-arginine was plotted against the known % L-arginine and 
the results indicated a reasonable fit, as shown in Figure 2.6 
D
L
F
F )0088.0(*18.212.5
0
  
Equation 2.4 
30 
 
   
 
Figure 2.6  Predicted % L-arginine versus actual % L-arginine at 10 mM total arginine. The 
predicted value was calculated using the experimentally determined F/F0 as the input to the fit 
equation, and the output (theta ratio) was converted to % L-arginine.
    
   
 
 It must be emphasized that careful control of the total arginine concentration is 
essential with this method: The calibration curve is developed at a specific concentration and 
will not apply at a significantly lower or higher concentration. In addition, although the 
adenosine results have relatively large error bars, the arginine system displays much smaller 
error bars, possibly due to the much greater solubility of arginine and the selectivity of the 
arginine aptamer.  
2.4 Conclusions 
A fluorescence-based chiral determination using RNA or DNA aptamers has been 
developed. It allows for the detection of enantiomeric ratios as low as 0.1:99.9 (L:D). Each 
sample is analyzed optically with a standard fluorimeter in a matter of minutes. Fluorescence 
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sensing is amenable to a high-throughput format, which increases productivity. No separation 
is required, therefore special equipment is not necessary and measurements can take place in 
disposable culture tubes. A calibration curve at a known concentration is generated, and from 
this an ER can be determined. Since SELEX can be used to obtain aptamers for a broad range 
of molecules and the structure-switching method has been demonstrated for the fluorescent 
determination of a number of targets, the method presented in this work should be applicable 
for the determination of enantiomeric ratios in numerous asymmetric catalysis processes.  
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3 1H NMR Evidence for Minimal Local Structural Change in the Pb2+-
specific 8-17 DNAzyme 
Notes and acknowledgements: The authors thank Dr. Nandini Nagraj for helpful 
discussions, Dr. Feng Lin for assistance with NMR data collection, and the US National 
Institute of Health (ES16865) and Department of Energy (DE-FG02-08ER64568) for 
financial support. This work is the basis of an unpublished manuscript, “1H NMR Evidence 
for Minimal Local Structural Change in the Pb2+-specific 8-17 DNAzyme.“ Eric L. Null, Jun 
Lin, Jing Li, Xiangli Meng, Xiaotang Wang, Sik Lok Lam, Zijian Guo, and Yi Lu. Manscript 
in preparation. 
3.1 Introduction 
3.1.1 The 8-17 DNAzyme and metal ion cofactors 
One of the most important discoveries in chemical biology in the past twenty years 
has been that DNA molecules can behave as enzymes, catalyzing a number of reactions 
analogous to protein and RNA enzymes. These DNAzymes, also known as deoxyribozymes 
or catalytic DNA, have been obtained through in vitro selection.1,2 Given the limitation in 
DNAzymes’ building blocks in comparison with proteins,3 it is not surprising that 
DNAzymes almost always require a cofactor to function, and that metal ions are the most 
common cofactor.4-7 Indeed, a number of DNAzymes have been selected that bind to a wide 
range of metal ion cofactors selectively and these DNAzymes have been converted into 
highly sensitive and selective sensors.8-10 Despite recognition of the prominent role of metal 
ions in the functioning of DNAzymes7 and demonstration of practical sensing applications,8-
10 the exact structure and mechanism of metal ion interactions with DNAzymes remain 
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poorly understood. A greater understanding of these interactions will advance our 
fundamental knowledge of bio-coordination chemistry. Furthermore, as it has been difficult 
to rationally design metal ion sensors and since these DNAzymes have been selected from a 
random DNA library to be highly specific for metal ions, such a study may provide guiding 
principles for designing other selective metal ion sensors. 
One excellent example is the 8-17 DNAzyme, isolated through in vitro selection 
under various conditions by several groups.11-15 After several surveys of metal ion-dependent 
activity,16,17 this DNAzyme was found to display high affinity for Pb2+ and was subsequently 
converted into highly sensitive and selective sensors for Pb2+ with fluorescence,18,19,9,20 
colorimetric,21,22 and electrochemical detection,23 and has been utilized in numerous other 
applications.24 Towards better understanding of the role of metal ions in the 8-17 DNAzyme, 
several biochemical16,25-29 and biophysical30-34 studies have been carried out. For example, 
Förster or Fluorescence Resonance Energy Transfer (FRET) studies,35,30,31,34 including single 
molecule FRET using an active DNAzyme construct,36 have revealed global folding in the 
presence of Zn2+ and Mg2+, but not in the presence of Pb2+, which is the most active metal 
ion. This result suggests that the selectivity for Pb2+ over other metal ions arises from a pre-
organized structure capable of binding Pb2+ with minimal or no structural change, similar to 
the lock-and-key mode in protein enzyme catalysis. FRET, however, is a low-resolution 
spectroscopic method and can only probe global folding; subtle local structural changes may 
not be detectable. Therefore, a higher resolution technique is needed to see if this DNAzyme 
is truly operating in a lock-and-key mode with Pb2+. 
Nuclear Magnetic Resonance (NMR) allows study of biomolecules in the solution 
state at atomic level.37 It has been used to elucidate structural information as well as metal 
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ion interactions in ribozymes successfully.38-48 The RNA-cleaving lead-dependent ribozyme 
or leadzyme discovered by Uhlenbeck et al.49,50 has been thoroughly characterized via NMR, 
including structure determination and dynamics studies.51,52,38,53,54 Despite the similarities of 
these two systems in terms of function (cleavage of a phosphodiester bond in the presence of 
Pb2+), the leadzyme has minimal affinity for metal ions other than Pb2+, with Mg2+ acting in 
an inhibitory manner.55-57 In addition to the more thoroughly studied leadzyme, the GR-5 
DNAzyme, an RNA-cleaving DNAzyme active with Pb2+,1 has also been studied by NMR, 
although interaction with Pb2+ was not characterized.58 Further investigation is necessary to 
understand the differences between these three systems and enhance understanding of metal 
ion specificity of DNA and RNA. 
While it is extremely difficult to carry out complete three dimensional structural 
determination of a DNAzyme structure by NMR, it is possible to use NMR for more detailed 
studies of local structural changes compared to those allowed by other techniques such as 
FRET. Therefore, we herein used 1H NMR to monitor metal ion-induced structural changes 
in the 8-17 DNAzyme and found that minimal spectral changes accompanied the high 
activity with Pb2+, while significant spectral changes were observed in the presence of Zn2+ 
and Mg2+ under metal ion concentrations that support enzymatic activity. In addition, few 
metal ion-dependent spectral changes were detectable if the essential G•T wobble pair close 
to the cleavage site was replaced with a G-C pair to render the DNAzyme inactive, 
confirming the importance of the wobble pair in metal ion binding.  
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3.2 Materials and methods 
3.2.1 Chemicals 
DNA and chemicals: DNA sequences were obtained either HPLC purified or 
desalted as appropriate from Integrated DNA Technologies, Inc. (Coralville, IA). Sodium 
MES was obtained from Sigma-Aldrich (St. Louis, MO) and metal salts (99.99%+) were 
obtained from Alfa Aesar (Ward Hill, MA).  
3.2.2 Sample preparation and instrumental characterization 
NMR sample preparation: DNA strands were dissolved in 50 mM sodium MES, pH 
6, diluted to the appropriate concentration, and dialyzed against the same buffer to insure 
consistent pH. Samples were then lyophilized and redissolved in 10% D2O in H2O. All NMR 
samples contained 670 µM each 17E and 17DS unless otherwise specified. Samples were 
annealed by heating to >55 °C and cooling to room temperature over ~1 hour. Metal ion 
titrations were accomplished by removing the sample from the NMR tube and adding the 
appropriate volume of concentrated metal ion solution with vigorous magnetic stirring. 
Samples were allowed to equilibrate for ten minutes before the start of acquisition. Samples 
containing Pb2+ were chloride free to minimize precipitation. To minimize or eliminate 
paramagnetic ion contamination metal ion stock solutions were made using at least 99.99% 
ultrapure salts and the utmost care was taken to keep the stocks free from contamination. 
Potentially significant amounts of contaminating paramagnetic ions could be present only at 
the highest concentrations of Mg2+, though such levels did not result in broadening when 
paramagnetic ions were tested independently (unpublished results). 
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1H NMR experiments: All proton NMR spectra of 17E and 17DS were collected on a 
600 MHz Varian UNITY INOVA spectrometer with a 5 mm Varian 1H{13C/15N} PFG X, Y, 
Z probe. The solvent signal was suppressed by either presaturation or jump-return pulse 
sequences with a relaxation delay of 2.0 seconds. Temperature was held constant at 25 °C 
unless otherwise stated. Chemical shift values were referenced to the solvent signal at 4.76 
ppm. Due to restrictions of sample concentration, ~160 scans were collected for each 1D 
spectrum. Where necessary, the chemical shift of each peak of interest was determined 
individually as long as the peaks, or a shoulder, were distinct. Upon merging, the shift of the 
merged peak was used when plotting data. Data was plotted using either Felix (Felix 
Corporate, Sandiego, CA) or MestReNova (Mestrelab Research, Santiago de Compostela, 
Spain). 
NOESY experiments: Phase-sensitive NOESY spectra were acquired at 25 C with 
mixing times ranging from 150 ms to 300 ms. Typical NOESY spectra were collected with 
256 experiments in F1 dimension using the hypercomplex method of States et al. In general, 
160 scans were accumulated for each F1 experiment, which was acquired with 4096 complex 
points in F2 dimension over a spectral width of 25 ppm. The solvent signal in all NOESY 
experiments was suppressed using a 1-3 s presaturation with a weak decoupler power. Data 
was plotted using Felix (Felix Corporate, Sandiego, CA). 
Assignment of the NMR peaks: Tentative assignment of peaks was accomplished via 
analysis of resonance properties such as chemical shifts and linewidths, examination of the 
spectral transformations induced by temperature changes and addition of different metal ions, 
with confirmation through 2-dimensional NOE measurements. The tentative assignments of 
peaks to which activity is correlated are as follows: peak 4, T2.3; peak 8, G1.1, and peak 9, 
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G1.2. Peaks 2 and 6 could not be assigned as peak 2 was not well resolved and peak 6 did not 
give NOE. Work is ongoing to assign these resonances and others.  
Activity assays: The assays were carried out using the same concentrations and 
conditions as in the NMR experiments described above (i.e., 670 µM each 17E and DS in 50 
mM sodium MES, pH 6). 17S substrate was 5′-labeled with γAT32P from PerkinElmer 
(Waltham, MA) using T4 kinase from Invitrogen (Carlsbad, CA). Approximately 1 nM 32P 
end-labelled 17S was added to the sample and then annealed as described above. An aliquot 
was removed immediately prior to the start of the assay and quenched in stop solution (7 M 
urea, 40% v/v formamide, 12% w/v Ficoll, 30 mM EDTA, 100 mM Bis-tris, and 0.05 % w/v 
each bromophenol blue and xylene cyanol), serving as the zero point. The assay was then 
initiated by addition of an appropriate amount of concentrated metal ion stock solution. 
Aliquots were quenched by addition to an excess of stop solution at intervals ranging from 
ten seconds to 24 hours as appropriate. The cleaved and uncleaved substrate were separated 
on a 20% denaturing polyacrylamide gel and quantitated using a Molecular Dynamics Storm 
430 phosphorimager (GE Healthcare, UK). After background subtraction, kinetic curves 
were plotted using Origin 8.1. and fit using the equation 
%Pt=%P0 + %P∞(1-e-kt) 
3.3 Results 
3.3.1 NMR spectral studies of the enzyme strand, substrate strand, and enzyme-
substrate complex 
The 8-17 DNAzyme consists of a DNA enzyme strand (17E) and a DNA substrate 
strand (17S) that contains an adenosine ribonucleotide (rA) in the middle as the cleavage site 
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(Figure 3.1). As a common practice in the NMR study of ribozymes and 
DNAzymes,38,58,39,43,45,47 the rA was replaced with an adenosine deoxyribonucleotide (A) 
(called 17DS, Figure 3.1) to prevent cleavage during data collection. 
 
Figure 3.1 Secondary structure of the 8-17 DNAzyme consisting of an enzyme strand (17E) 
and a substrate strand (17S). Mutation of the riboadenosine at the cleavage site to adenosine 
results in an inactive substrate strand (17DS). Mutation of T2.1 to C on the enzyme strand 
(17E T2.1C) results in G-C base pair formation between the enzyme strand and substrate 
strand, replacing the G·T wobble pair and forming an inactive construct. 
As shown in Figure 3.2A, the 17E or 17DS strands alone displayed only broad NMR 
spectra, suggesting minimal structure formation. In contrast, when equal concentrations of 
the 17E and 17DS strands were hybridized, the enzyme/substrate complex displayed much 
sharper NMR peaks in the general region of imino proton resonances (between 11.5 and 13.5 
ppm for G-C base pairs and between 13 and 15 ppm for A-T base pairs), indicating that the 
8-17 DNAzyme forms a more well-defined three-dimensional structure as in protein enzymes 
and ribozymes; such a well-defined structure must be important for its efficient catalytic 
function. There is significant change in the spectrum upon cooling as seen in Figure 3.2B. It 
is known for the 8-17 DNAzyme that reduction of temperature to 4°C resulted in 
significantly slowed release of the cleaved substrate strand, though activity remained.59 
Though there are changes, the number of observed NMR peaks do not appear to increase 
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dramatically at reduced temperature where stronger hybridization is known to occur, 
providing further support for a well-formed construct at room temperature. 
 
Figure 3.2 Proton NMR spectra of the imino proton region of A) the 8-17 DNAzyme 
enzyme strand (17E) or substrate strand (17DS) alone at 750 μM each; and B) the 8-17 
DNAzyme enzyme-substrate complex (17E+17DS, 670 μM each) at different temperatures. 
3.3.2 Metal ion titrations monitored by proton NMR 
To investigate the effect of metal ions on the structure of the 8-17 DNAzyme, we 
carried out metal ion titration experiments while monitoring spectral changes with 1H NMR. 
The effect of Zn2+ was examined first, as it is one of the more active metal ions in terms of 
cleavage efficiency and was used in the in vitro selection to obtain the 8-17 DNAzyme.13 As 
shown in Figure 3.3A, addition of increasing equivalents of Zn2+ resulted in changes of many 
peaks. The two resonances at 13.99 and 13.89 ppm (called peaks 1 and 2) are effectively 
merged at 0.5 eq Zn2+. In addition, peak 6 at 13.04 ppm increased in intensity and peak 9 at 
12.52 ppm split.  
In contrast, addition of up to 2.5 equivalents of Pb2+ resulted in minimal changes in 
the NMR spectra (Figure 3.3B). The only change noted is the splitting of peak 9 at higher 
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equivalents. In addition to Zn2+ and Pb2+, Mg2+ is also known to support 8-17 DNAzyme 
activity, but does so at much higher concentrations than either Zn2+ or Pb2+.16,17,30 Upon 
addition of a similar number of equivalents (e.g., 2.5 eq.) of Mg2+ as for Zn2+ and Pb2+, few 
NMR changes were observed (Figure 3.3C). Since these numbers of equivalents are not 
sufficient to support Mg2+-dependent enzymatic activity, the NMR titration was continued at 
higher equivalents where the DNAzyme is more active. Significant changes in the 1H NMR 
spectrum with up to 75 equivalents are noted. Analogous to what was observed upon Zn2+ 
addition, though different in terms of peaks affected, obvious changes in the NMR resonance 
pattern were observed upon Mg2+ addition, including merging of peaks 1 and 2, merging of 
peaks 3 and 4, and a downfield shift of peak 6 at >5 equivalents Mg2+. 
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Figure 3.3 1H NMR spectra of the 8-17 DNAzyme in the presence of increasing equivalents 
of A) Zn2+, B) Pb2+, and C) Mg2+. Splitting or merging is indicated by the direction of sets of 
horizontal arrows and a vertical arrow indicates an increase or decrease in intensity. Peak 
numbers are assigned arbitrarily from downfield to upfield. 
3.3.3 Correlation of the NMR spectral changes with enzymatic activity 
While it is interesting to compare NMR spectral changes of the 8-17 DNAzyme upon 
metal ion addition, it is important to correlate the changes with enzymatic activities. 
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Therefore, activity assays were performed under the same solution conditions used in the 
proton NMR studies and the raw traces are shown in Figure 3.4. 
 
Figure 3.4 Activity assays of the 8-17 DNAzyme in the presence of increasing equivalents of 
A) Zn2+, B) Pb2+, and C) Mg2+. 
In order to correlate the variation in chemical shift change, Δδ (taken as the ppm 
value for a given peak minus the ppm value of the same peak in the absence of M2+), with the 
activity assay data, we plotted Δδ and observed rate (kobs/min-1) against the equivalents of 
M2+ (and M2+ concentration) on the same plot for several representative peaks, chosen since 
they incurred varying degrees of movement upon addition of metal ions. As shown in Figure 
3.5A, peak 2 moves >0.1 ppm with increasing equivalents of Zn2+ added and such movement 
correlates well with the increase of kobs at the same equivalents of Zn2+, suggesting a strong 
correlation between the DNAzyme activity and Δδ. In addition, a ~0.06 ppm Δδ for peak 8 
and splitting of peak 9 are noted upon addition of Zn2+, whereas changes of peaks 4 and 6 
were minimal. Addition of either Zn2+ or Mg2+ induced spectral changes in peak 2. 
Interestingly, while peak 6 exhibited minimal change with increasing equivalents of Zn2+, the 
same peak shifted downfield with increasing equivalents of Mg2+. On the other hand, even 
though a significant shift of peak 8 was noted upon Zn2+ addition, minimal change of peak 8 
was observed upon Mg2+ addition. Despite these differences, the NMR spectra changed 
significantly upon addition of either Zn2+ or Mg2+ within the concentration range that 
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supports their respective activity. In contrast, spectral change is minimal in the presence of 
Pb2+ equivalents that support full activity. 
 
Figure 3.5 The observed rate (kobs) and Δδ are plotted simultaneously against the equivalents 
and concentration of A) Zn2+, B) Pb2+, and C) Mg2+ for peaks 2, 4, 6, 8, and 9. 
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3.3.4 NMR study of the 8-17 DNAzyme variant with a G1.1·T2.1 wobble pair → G1.1-
C2.1 pair mutation 
 One hallmark feature of the 8-17 DNAzyme is the presence of a G1.1·T2.1 wobble pair 
that is known to be essential for catalysis12 (Figure 3.1); replacing this wobble pair with a G-
C base pair through a G1.1·T2.1 → G1.1-C2.1 mutation renders the enzyme inactive. Since the 
single mutation has such a drastic effect on the enzymatic activity, we used proton NMR to 
investigate the effect of this T2.1→C mutation on the DNAzyme by following spectral 
changes upon metal ion addition.  
As shown in Figure 3.6, mutation of the G1.1·T2.1 wobble pair to G-C resulted in an 
upfield shift of peak 2 by 0.6 ppm and appearance of a new peak at 12.68 ppm in the NMR 
spectral region where G-C pairs normally reside. These results suggest that the active site is 
perturbed upon mutation, resulting in a strong new G-C pair, and that peak 2 corresponds to a 
base in proximity to the active site, further supporting the relevance of spectral changes 
associated with this peak upon metal ion addition. Interestingly, the Sen group observed a 
different cross-linking pattern when the G·T wobble pair was mutated to a regular G-C base 
pair.25  
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Figure 3.6 1H NMR spectra of the 8-17 DNAzyme with and without the G1.1·T2.1 wobble pair 
→ G1.1-C2.1 pair mutation. The black arrow indicates a new peak upon formation of the G-C 
pair and the dropped line indicates a shift in the A-T base pair region. 
As distinct changes to the proton NMR spectrum are observed upon T2.1→C 
mutation, metal ion titrations were undertaken analogous to those for the wobble pair 
construct in order to study the effect of the T2.1→C mutation on the pattern of changes upon 
metal ion addition. Interestingly, instead of significant movement of the NMR peaks as 
observed with the original 8-17 DNAzyme (see Figure 3.3A), addition of Zn2+ to the T2.1→C 
mutant resulted in fewer changes in the NMR spectra, with only minimal splitting noted 
(Figure 3.7A). As noted in Figure 3.3B, addition of 2.5 eq. Pb2+ to the wobble pair construct 
resulted in splitting of peak 9; such splitting is not noted under the same conditions with the 
base-paired construct (Figure 3.7B). 
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Figure 3.7 1H NMR spectra of the 8-17 DNAzyme variant with a G1.1·T2.1 wobble pair → 
G1.1-C2.1 pair mutation upon addition of either A) Zn2+ or B) Pb2+. Arrows denote peaks that 
change in a different manner compared to 17E+DS upon metal ion addition, due to the 
T2.1→C mutation. 
3.4 Discussion 
3.4.1 The 8-17 DNAzyme forms a well-defined 3D structure 
 
A common perception of DNA structures is that they display either double helices 
formed by double stranded DNAs or random floppy structures formed by mostly single 
stranded DNAs. Neither double helices nor random structures are enough to support catalysis 
due to minimal structural diversity of double helices and low stability of random structures. 
A well-defined 3D structure has been shown to be a prerequisite for most protein enzyme 
catalysts, and NMR spectroscopy is an excellent technique for determining if such a well-
defined structure exists; broad or featureless NMR spectra are often indicative of a random 
ill-defined structure while many sharp NMR peaks suggest well-defined structures. This is 
particularly true in the case of the imino proton region where signals are seen only upon base 
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pair formation due to slowed proton exchange with the solvent. As shown in Figure 3.2, the 
enzyme strand (17E) or substrate strand (17DS) alone indeed displays broad featureless 
NMR spectra, like most other single stranded DNA with random structures. However, after 
the enzyme and substrate are annealed together, the complex exhibits many sharp NMR 
peaks at three different temperatures, indicating that the 8-17 DNAzyme forms a well-
defined 3D structure, just like other protein enzymes and ribozymes, which is required for 
efficient catalysis. 
To aid in discussion of the data obtained in this study, a tentative assignment of 
several peaks was accomplished via analysis of resonance properties such as chemical shifts 
and linewidths, examination of the spectral transformations induced by temperature changes 
and addition of different metal ions, with confirmation through 2-dimensional NOE 
measurements. The tentative assignments of peaks to which activity is correlated in Figure 
3.5 are as follows: peak 4, T2.3, peak 8, G1.1, and peak 9, G1.2. The NOESY spectrum and 
several other assignments are shown in Figure 3.8. Peaks 2 and 6 were not assigned as peak 2 
was not well resolved and peak 6 did not give NOE. Interestingly, the above peaks that are 
assigned and correlate with activity are either in or close to the proposed active site. 
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Figure 3.8 Contour plot of the imino proton-imino proton region of a 250 ms mixing time 
NOESY spectrum of the 8-17 DNAzyme collected in H2O showing the NOE connectivities 
between hydrogen bonded imino protons. The spectrum was collected at 10 C in 50 mM 
MES sodium buffer at pH 6.0. The jump-return method was used during acquisition to 
suppress the intense water signal. Cross-signal assignments are as follows. (1) T2.8:G1.7; (2) 
T2.6:G1.7; (3) G1.2:T2.3; (4) T2.1:G1.1; (5) T2.3:T2.4; (6) T2.8:T1.9; (7) T1.9:G1.10; (8) T2.1:G1.2  
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3.4.2 Changes in proton NMR spectra correlate with activity  
Metal ion titrations were performed while monitoring changes in the proton NMR 
spectrum and activity assays were performed under the same conditions, allowing correlation 
of changes in the proton spectra with enzymatic activity. Addition of Zn2+ resulted in a 
downfield shift of peak 2 and subsequent merging with the peak corresponding to T2.8, and 
splitting of G1.2. All of these changes occurred upon addition of ≤5 eq. Zn2+, by which point 
maximum activity and % cleavage had been reached (raw % cleavage data may be found in 
Figure 3.4). As the most significant changes in the NMR spectrum were observed below 2.5 
eq. Zn2+, these results suggest that a local structural change around the Zn2+-binding site was 
required to achieve full activity. Alternatively, the observed NMR spectral changes may be 
due to electronic effects from Zn2+-binding, without any structural change. However, the 
latter interpretation is not consistent with results from FRET and single molecule FRET 
studies,35,30,36,31 which showed significant global folding, i.e., structural changes, upon 
addition of Zn2+ under similar conditions. It should also be noted that a perfect correlation 
between activity and Δδ is not expected in part due to comparison of the active DNAzyme 
containing a riboadenosine at the cleavage site and the NMR titrations in which the inactive 
construct containing adenosine was used.  
In contrast to the spectral changes upon Zn2+ titration, addition of up to 2.5 eq. Pb2+, 
the most active metal ion, resulted in no major changes in the NMR spectrum (Figure 3.3B). 
The corresponding activity assay showed that maximum % cleavage is reached upon addition 
of 1 eq. Pb2+ (Figure 3.4) and maximum activity is reached by 2.5 eq. Pb2+ (Figure 3.5B), and 
as such any structural changes necessary to reach maximum activity are expected to occur 
before this point. A 0.03 ppm shift was observed for G1.1 and splitting was observed for G1.2 
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at higher eq. Pb2+. As no other significant effects on the NMR spectrum were observed, such 
changes are attributable to specific interaction of the residues with Pb2+. Similarly, an NMR 
study of the leadzyme, a ribozyme, has indicated shifts of ~0.01 ppm in the imino proton 
region for all resonances except for G2.2 which shifted ~0.06 ppm and was attributed to 
localization of Pb2+, not structural change, as no other major spectral changes were 
observed.51 This result is also interesting as it indicates localization of Pb2+ close to the 
wobble pair. Since addition of Zn2+ at concentrations that support activity results in 
significant NMR spectral changes, but addition of Pb2+ does not, these results together with 
those from previous FRET studies35,30,36,31 are consistent with a “lock-and-key” mode of 
catalysis for Pb2+, in that minimal structural rearrangement is necessary in order to achieve 
high activity. 
The 8-17 DNAzyme is also active with Mg2+, though to a lesser extent than with Pb2+ 
or Zn2+. Proton NMR titrations and activity assays were performed and few changes in the 
proton spectrum were observed upon addition of 2.5 eq. Mg2+ (similar to the number of eq. 
tested for Zn2+ and Pb2+), with only small shifts in peaks 2 and 6 observed (Figure 3.3C). 
However, the enzymatic activity at 2.5 eq. Mg2+ is minimal (Figure 3.5C), which is different 
from Zn2+- (Figure 3.5A) and Pb2+- (Figure 3.5B) dependent catalysis. Therefore, the activity 
assays and NMR titration were continued at higher equivalents. The activity assay suggests 
that greater than 50 eq. Mg2+ are required to display maximum activity. Correlating with 
activity, significant changes in the NMR resonance pattern are noted below 50 eq. Mg2+ 
including ~0.05 ppm Δδ for peaks 2 and 6, indicating that rearrangement is necessary to 
reach maximum activity as is the case with Zn2+. This data also matches well with previous 
FRET studies which provided evidence for global folding in the presence of Mg2+.30,36,31  
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The significant NMR spectral changes for Zn2+ and Mg2+ in and of themselves do not 
necessarily imply an induced-fit mode of catalysis for these two metal ions. Alternatively, a 
small population of Zn2+- or Mg2+-bound DNAzyme that is very active may exist which uses 
a lock-and-key mode of catalysis similar to Pb2+. Such a population may not be observable 
due either to low population or rapid equilibrium on the NMR time scale. Therefore, most of 
the DNAzyme population would be inactive, but undergoes conformation change upon metal 
binding, leading to the observed spectral changes upon Zn2+ or Mg2+ addition. Although we 
cannot rule out such a possibility completely, this interpretation is not consistent with results 
from FRET and single molecule FRET studies, which showed that a conformational change 
was required before activity was observed,30,31 and no major population of DNAzyme that is 
inactive was present.36 
3.4.3 The 8-17 DNAzyme is one of the three Pb2+-specific nucleic acid enzymes 
An NMR study of the Pb2+-specific GR-5 DNAzyme,58 the first DNAzyme obtained 
by in vitro selection, has been undertaken. However, detailed studies on metal ion 
interactions with this DNAzyme have not been reported. On the other hand, more thorough 
NMR studies have been carried out on a Pb2+-specific ribozyme called the leadzyme. 
Therefore it is interesting to compare the results presented here with those of the leadzyme in 
order to find out if there are any differences and similarities between DNA- and RNA-based 
enzymes. 
The leadzyme and the 8-17 DNAzyme are similar in their phosphodiester cleavage 
activities on a ribonucleotide, as the log of the cleavage rate is linear with respect to pH, 
indicating a single deprotonation event as the rate-determining step.55,60 However, the metal 
selectivity is rather different. The leadzyme is very selective for Pb2+, possessing minimal 
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activity with a host of other metal ions,56,57 while the 8-17 DNAzyme is also active in the 
presence of several metal ions such as Zn2+, Co2+, and Mg2+, even though the selectivity for 
Pb2+ over other active metal ions is at least two orders of magnitude. Perhaps the major 
difference in metal ion selectivity is that Mg2+ inhibits the reaction of the leadzyme,55 while it 
promotes the reaction of the 8-17 DNAzyme. 
Several NMR studies on the leadzyme have shown that addition of either active Pb2+ 
or inhibitive Mg2+ resulted in minimal structural perturbation at 100 mM NaCl.52,53 In the 
case of the 8-17 DNAzyme, however, Mg2+ and Zn2+ not only support activity, but also 
display observable changes in the NMR spectra and thus conformational changes. These 
differences show that the DNAzyme and ribozyme behave differently in the presence of 
metal ions. 
3.4.4 Mutation of the G1.1·T2.1 wobble pair to a G-C base pair significantly decreases 
Zn2+ interaction with the DNAzyme and thus affects the activity 
The G1.1·T2.1 wobble pair has been shown to be essential for catalysis as mutation to a 
G-C base pair eliminates enzymatic activity.16 Comparison between the proton NMR 
spectrum of the original 8-17 DNAzyme with the G1.1·T2.1 wobble pair and the variant with 
the G-C base pair shows that the T2.1 → C mutation results in formation of a new peak 
corresponding to a G-C base pair and significant perturbation of peak 2, indicating that the 
mutation has a direct impact on the structure. More importantly, fewer spectral changes were 
observed upon Zn2+ addition to the variant with the G-C base pair, suggesting a significant 
decrease in metal-DNAzyme interactions. These results provide a strong structural basis for 
the effect of the mutation on the activity and suggest that the G1.1·T2.1 wobble pair may be 
involved in metal ion binding.  
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3.5 Conclusions 
This 1H NMR study of the 8-17 DNAzyme has provided strong evidence for minimal 
local structural change in the presence of the most active metal ion (Pb2+), while other active 
metal ions (Zn2+ and Mg2+) exert significant perturbations to the local structure. Together 
with previous FRET studies of global folding,30,36,31 the results suggest that the DNAzyme 
uses a lock-and-key mode of catalysis in the presence of Pb2+. In addition, a comparison of 
the metal ion-dependent NMR spectral changes of the native DNAzyme (containing the 
essential G•T wobble pair close to the cleavage site) with an inactive variant (containing a G-
C pair at the same position) suggests the importance of the wobble pair in metal ion binding. 
These results have advanced our understanding of the role of metal ions in this new class of 
metalloenzymes and provide a basis for rational design of other metal ion sensors. Work is 
under way to assign the NMR peaks completely in order to obtain an NMR structure of the 
DNAzyme, and once an NMR structure is obtained, it may be very interesting to investigate 
the specifics of rearrangement necessary to accomplish activity with Zn2+ and Mg2+ as well as 
dynamic processes important to catalysis. 
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4 Investigating Potential Metal Ion Binding Sites of the 8-17 DNAzyme 
through Phosphorothioate Modifications and 31P NMR 
Notes and Acknowledgements: The work in this chapter was done in collaboration with 
Nandini Nagraj (project initiation and activity assays) and Seyed-Fakhreddin Torabi (activity 
assays). We also thank Dr. Feng Lin for his assistance with 31P NMR experiments. This work 
also appeared in the thesis of Nandini Nagraj and is the basis of an unpublished manuscript, 
“Investigating potential metal-binding sites of the 8-17 DNAzyme through phosphorothioate 
modifications and 31P NMR.” Nandini Nagraj,* Eric L. Null,* Seyed-Fakhreddin Torabi, and 
Yi Lu. In preparation.*Equal contributing authors 
4.1 Introduction 
4.1.1 Insights into the mechanism of the 8-17 DNAzyme 
Extensive characterization studies of the 8-17 DNAzyme have been previously 
carried out based on various biochemical probing methods.1-7  Like most ribozymes and 
DNAzymes, the 8-17 DNAzyme depends on divalent metal ions for activity. The DNAzyme 
activity is the highest in the presence of Pb2+, following the order: Pb2+ >> Zn2+ >> Mn2+ ≈ 
Co2+ > Ni2+ > Mg2+ ≈ Ca2+ > Sr2+ ≈ Ba2+, in spite of the fact that the 8-17 motif was selected 
under varying conditions and with metal ions other than Pb2+.8,2,5 This DNAzyme is a highly 
efficient enzyme with its maximum reaction rate estimated to be ~ 220 min-1 in the presence 
of 200 µM Pb2+ at physiological pH (7.5), which is among the highest in DNAzymes and 
ribozymes.2 
 Systematic modifications of bases through the introduction of non-standard 
nucleotides in the catalytic core of the 8-17 DNAzyme (Figure 4.1) have been carried out and 
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the activies of these modified DNAzymes have been calculated through kinetic assays.3,5 The 
results of these studies correlated well with the original in vitro selection results obtained by 
Santoro and Joyce and the impact of mutations on the overall activity of the DNAzyme was 
postulated.9 Photo cross-linking studies have also been undertaken by Liu and Sen to 
investigate the cross-linking patterns and proximity between different bases and the scissile 
site of the substrate.6 This has been done by systematic replacement of each of these bases 
with the thio- and halogen-substituted base analogues, followed by photochemical activation 
to yield cross-links within the enzyme-substrate complex, in the presence of 10 mM Mg2+. A 
model of the active site of the 8-17 DNAzyme was then proposed which was thought to be 
generally representative of the pre-folded active site in the presence of both lower and higher 
Mg2+ concentrations.6 Photo cross-linking has also revealed different modes of activity for 
Pb2+ under low versus moderate ionic strength10 and iodine-mediated crosslinking has 
provided stereochemical information in regards to the active site.11 The effect of various 
monovalent and divalent ions on the activity, global folding, and structure formation of the 8-
17 DNAzyme has been previously studied. It was observed from both bulk and single-
molecule FRET studies that Pb2+, the most efficient co-factor of the 8-17 DNAzyme, did not 
cause any folding of the enzyme-substrate complex before cleavage activity.12,13 Folding 
behavior was recently reexamined in the presence of varying dinucleotide cleavage junctions, 
reinforcing the known cleavage order.14 Selective replacement of bases with either an abasic 
site or spacer has shown a great deal of plasticity in the 8-17 DNAzyme while confirming the 
importance of the conserved bases.15 In addition, no structural change from the right-handed 
B-form to the Z-form was observed with Pb2+, whereas, in the presence of sufficient 
concentrations of other divalent and monovalent metal ions, the 8-17 DNAzyme folded to 
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form a more compact structure prior to activity.16 Circular dichroism (CD) measurements 
also indicated a structural change from the B-form to the Z-form in the presence of sufficient 
concentrations of these metal ions. This led to the proposition that the 8-17 DNAzyme might 
form a special pocket to accept Pb2+ or was structurally pre-organized through directed 
evolution to accept and catalytically utilize Pb2+.  
 
 
Figure 4.1 Predicted secondary structure of the trans-cleaving 8-17 DNAzyme showing the 
conserved residues in blue and indicating positions of the nucleotides based on the 
numbering system proposed by Peracchi et al.1,5 The bold lines represent nucleotides on the 
helical regions while the thin lines represent Watson-Crick base pairs across these helices. 
 
Replacement of the P-O bond of a phosphate group by a P-S bond (Figure 4.2) is 
referred to as a ‘phosphorothioate (or PS) modification’.17,18 Although the P-S bond is only 
0.3 Å longer than the P-O bond, and there is no intrinsic difference in activity between P-O 
and P-S,19-21 the negative charge of the P-S bond is localized to a greater extent on the more 
polarizable sulfur22,23 and there is a significant difference in terms of reactivity toward 
different metal ions. Therefore, divalent metal ions that have been traditionally classified as 
‘hard’ such as the alkaline earth metals, prefer binding to the phosphate oxygen, while metal 
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ions such as Cd2+ that are traditionally classified as ‘soft’ prefer binding to sulfur. There are 
‘borderline’ metal ions that can bind both oxygen and sulfur, including Pb2+, Co2+, Zn2+ and 
Mn2+.  
 
 
Figure 4.2 Schematic representation of a phosphate to a phosphorothioate modification on 
the DNA backbone. 
 
Site-specific phosphorothioate labeling on the phosphate backbone of ribozymes has 
been used extensively to predict important structural and functional sites relevant to 
catalysis.24-28 Metal-specificity switch or phosphorothioate interference experiments have 
been used to probe metal ion binding of ribozymes, on the basis of the differing affinities of 
metal ions toward oxygen and sulfur.29-31 According to the HSAB (Hard Soft Acid Base 
theory),32 a reduction in the cleavage of a ‘soft’ thio-substituted substrate (of the ribozyme) 
should be observed in the presence of a ‘hard’ Mg2+ cation (the thio effect). Restoration to a 
normal cleavage rate, of a sulfur-containing substrate, should occur in the presence of a 
thiophilic cation such as Cd2+ (the rescue effect). This rescue in the activity of the ribozyme 
has been generally accepted as evidence of functional metal-binding to the site of 
substitution. The mechanistic aspect of ribozymes, including the group I and II introns,33-35 
 61 
the RNA subunit of RNase P,36,37 and the hammerhead,38-46 has been explained to a greater 
degree through the analysis of these types of interactions. Interpretation of these results is 
complicate, and quite often debated47-49 due to the ability of divalent metal ions to cause 
structural and steric effects on the ribozyme. Results from ribozyme crystal structures 
demonstrating metal ion localization, however, correlate well with the metal-binding sites 
observed using PS modifications, providing support for PS modifications as an important 
technique. Results obtained from PS modifications have also been complemented using 
additional probing techniques such as 31P NMR, EPR, and ENDOR of PS-modified 
ribozymes to determine metal-binding sites.50,42,43,51,49,52  
Recently, mapping of the functional phosphate groups in the catalytic core of the 10-
23 DNAzyme was reported.53 These experiments suggested that both oxygens at the P5 
phosphate position and the pro-RP oxygen at the P9 position played a role in metal 
coordination. In addition, the authors found that oxygen at the C6 position on the G6 base 
contributed to metal ion binding and that interaction was essential for the catalytic activity of 
the10-23 DNAzyme.53 
4.1.2 Research goals 
Over the last decade, considerable attention has been directed towards isolating (and 
subsequently understanding the mechanism of) laboratory-evolved DNAzymes for various 
applications. Elucidating the role of metal ions as well as nucleotide bases in the activity and 
folding of the 8-17 DNAzyme has been investigated.12,13,54,55,16 Obtaining a crystal structure 
for this DNAzyme (or a functional structure for any DNAzyme to date),56 however, has thus 
far proved to be extremely challenging. PS modifications on the backbone of ribozymes have 
proved to be very insightful for elucidation of their mechanism and crystallographic data 
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obtained for several ribozymes correlates well with PS results, providing strong evidence of 
the reliability of PS modifications for identification of functional metal ion binding sites. The 
use of 31P NMR by DeRose and co-workers44,46 has been a valuable tool in directly viewing 
interactions of metal ions with specific phosphates of the hammerhead ribozyme. Herein we 
detail our efforts in identifying functional phosphates on the backbone of the 8-17 
DNAzyme, in the presence of Pb2+, through single PS modifications on previously identified 
conserved residues using both kinetic assays and 31P NMR. A PS modification at the active 
site has been used for crosslinking, allowing probing of proximity to the backbone in a cost 
effective and isostructural manner, though activity was not the focus of the study.11 This is 
the first systematic study elucidating the role of the phosphates as potential metal ion binding 
sites on the 8-17 DNAzyme and it is anticipated that the results obtained during this study, in 
addition to the various biophysical and biochemical characterizations, will give us a better 
mechanistic understanding of this DNAzyme. 
4.2 Materials and methods 
4.2.1 Materials  
All oligonucleotides were obtained desalted from Integrated DNA Technologies Inc. 
(Coralville, IA) and purified by Poly-Acrylamide Gel Electrophoresis (PAGE) for kinetic 
assays. Oligonucleotides containing PS modifications were obtained as racemic mixtures, 
containing both the RP and SP stereoisomers, and were used without any chiral separation. 
Oligonucleotides for 31P NMR were used as obtained for sample preparation described in the 
following section (gel purification was not performed). All metal salts used were obtained 
from Alfa-Aesar (Ward Hill, MA) and were of Puratronic® grade, 99.999 % pure. [γ-32P]-
adenosine 5′-triphosphate (ATP) was obtained from Perkin Elmer (Waltham, MA) and T4 
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kinase was obtained from Invitrogen/Life Technologies (Carlsbad, CA) or New England 
Biolabs, Inc., (Ipswich, MA). All other chemicals were of at least ACS reagent grade and 
were purchased from either Sigma-Aldrich (St. Louis, MO) or Thermo Fisher Scientific, Inc. 
(Waltham, MA). 
4.2.2 Kinetic assays 
The substrate oligonucleotide (17S) was 5'-radiolabeled with [γ-32P]-ATP using T4 
kinase, purified on a C18 Sep-Pak® cartridge (Waters Corporation, Milford, MA), and stored 
at -20 °C. All kinetic assays were carried out under single-turnover conditions with 5 µM 
enzyme and 0.5 -1.5 nM substrate, in a buffer containing 50 mM MES-HCl, pH 6.0, and 100 
mM NaCl. The sample solution containing the enzyme and substrate in buffer (Figure 3a) 
was denatured at 95°C in a water bath and then annealed by gradual cooling to room 
temperature over ~ 45 minutes. After annealing the solution, a 5 µL aliquot was added to 25 
µL of a ‘stop solution’ containing 8 M urea, 1× TBE, and 0.05 % w/v each bromophenol blue 
and xylene cyanol in a 96-well plate. This was the ‘zero-point’ control before the initiation of 
the reaction. Thereafter, appropriate volumes of metal solutions were added to the sample to 
initiate the reaction and 5 µL aliquots were taken at suitable time intervals and added to the 
stop solution to quench the reaction on a 96-well plate. The final concentrations of Pb2+ and 
Zn2+ used for the assays were 100 µM, while 10 mM Mg2+, Cd2+ , Mn2+ and 2.5 mM each of 
Cu2+ and Cu+ were used. The uncleaved substrate and the cleaved product were separated on 
a denaturing 20 % polyacrylamide gel, imaged on a Molecular Dynamics Storm 430 
phosphorimager, and quantified using Image-Quant software (GE Healthcare, UK). The 
percent product at time ‘t’ was calculated by taking the ratio of the 5'-cleaved product to the 
total of the cleaved product and the uncleaved substrate, after subtraction from the 
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background radioactivity on the gel. Kinetic plots were created using Origin 8.5 software 
(OriginLab Corporation, Northampton, MA) and fit to the equation 
 % Pt =  % P0 + % P∞ (1-e-kt) 
where % P0 is the initial amount of product (at time, t = 0), % P∞ is the amount of product 
formed at the endpoint of the reaction ( at t = ∞ ), % Pt is the amount of product at time t, and 
k = kobs, the observed rate constant. 
4.2.3 31P NMR studies 
For the 31P NMR studies, the concentrations of the enzyme and substrate (Figure 
4.3b) were maintained at 670 µM each in 50 mM MES sodium, pH 6.0, in 10 % D2O. The 
cleavage site on the substrate strand (17S) was replaced by a non-cleavable 
deoxyriboadenosine base (17DS) to prevent cleavage during data collection. Samples were 
prepared by first dialyzing equal amounts of the enzyme and substrate strands in buffer 
containing 50 mM MES sodium, pH 6.0, against the same buffer, followed by lyophilization. 
The samples were re-dissolved in 10 % D2O, and then denatured at 55 °C in a water bath 
followed by gradual cooling to room temperature to ensure complete hybridization. 31P NMR 
spectra were collected at 242.8 MHz on a Varian UNITY INOVA spectrometer with a 5 mm 
AutoTuneX probe. Temperature was held constant at 25 °C and samples were referenced 
using an internal coaxial tube containing either 5 % 5'-thymidine monophosphate (4.15 ppm) 
or trimethyl phosphate (3.70 ppm) in D2O. Metal ion titrations were carried out at room 
temperature by removing the sample from the NMR tube and adding either a 100 mM or 200 
mM M2+ solution as appropriate, with constant magnetic stirring. Samples containing Pb2+ 
were chloride-free to minimize precipitation. Samples were allowed to equilibrate for ten 
minutes before the start of acquisition. 
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Figure 4.3 Predicted secondary structures of a) 17ES DNAzyme-substrate complex used for 
the kinetic assays, b) 17EDS DNAzyme-substrate complex containing a non-cleavable 
adenosine base at the cleavage site, used for 31P NMR studies. The positions of the PS 
modifications used for both the kinetic and NMR studies are indicated in Table 5.1. c) 
Duplex control used for 31P NMR that contains a fully complementary sequence to the 
17EA15PS enzyme strand. 
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4.3 Results  
4.3.1 Dependence of DNAzyme activity on the position of the PS modification  
The roles of the phosphates adjacent to several bases of the 8-17 DNAzyme 
implicated previously in catalysis,57 were probed using phosphorothioate modifications. A 
single replacement of the P-O bond by P-S was made 5′ to each of the individual bases 
implicated in catalysis, and the rate of cleavage upon modification was systematically 
studied. The thio effect, which was representative of the extent of perturbation upon a PS 
modification, was calculated in the presence of Pb2+ and rates of the cleavage reaction were 
also calculated in the presence of a range of soft metal ions that included Cd2+, Mn2+, Cu+, 
borderline soft (namely Zn2+), and also in the presence of Mg2+ which is classified as a hard 
metal ion. Activity assays were also carried out in the presence of Cu2+ as a control for the 
Cu+ studies.  
4.3.2 Activity of modified DNAzymes with Pb2+  
As shown in Figure 4a, the DNAzymes with PS modifications at positions G14 and 
A15 showed negligible activity and therefore maximum perturbation with 100 µM Pb2+. In 
comparison, the PS modifications 5′ of positions G7 and T16.2 did not result in significant 
perturbation and the kinetic rate constants obtained were almost the same as that obtained 
with the unmodified 17E DNAzyme. Modifications at positions C8, C3, A15.0, and C9 did lead 
to some perturbation and an overall loss in activity in comparison with the unmodified 17E 
DNAzyme by approximately 1-2 orders of magnitude, respectively. The overall activity, 
however, was still quantifiable in comparison with enzymes containing modifications at 
positions G14 and A15. In fact, a ratio of the rate constants of the unmodified 17E DNAzyme 
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to PS-modified enzyme, known as the thio effect (shown in Table 4.1), range from ~1.0 in 
the case of G7 and T16.2 (highlighted in red Table 4.1), to intermediate values between 20 and 
60 in the case of A15.0,C3, and C8 ( highlighted in blue); to extremely perturbed with thio 
effects of ~265 and unquantifiable in the case of C9, G14, and A15 (highlighted in green), 
respectively. PS modifications at the cleavage site, namely between the RNA base on the 
substrate strand and the wobble pair (17SG1.1PS), interestingly showed a relatively small thio 
effect of ~3; however, upon PS substitution on the G1.2 of the G·T wobble pair, the observed 
rate of the reaction was faster than even the unmodified enzyme-substrate complex and a thio 
effect <1 was observed. (Table 4.1). 
4.3.3 Activity of modified enzymes with other metal ions 
Interestingly, when the kinetic assays of the DNAzyme with any PS modification on 
the enzyme strand were performed with 10 mM Mg2+ and 10 mM Cd2+ , which are at the two 
extremes of the hard-soft metal ions scale, no significant difference in kobs values were 
observed in comparison with the unmodified 17E DNAzyme as shown in figure 4b and 4c. 
(Initial experiments with 1 mM Mg2+ and 1 mM Cd2+ after ~24 hours did not yield any 
activity even with the unmodified 17ES DNAzyme and hence a concentration of 10 mM was 
chosen). The thio effects (shown in Table 4.1) ranged from ~1 to 2.8 with 10 mM Cd2+ and 
from ~1 to 3.5 with 10 mM Mg2+. In contrast, many of the single PS substitutions on the 17E 
DNAzyme perturbed the activity with 100 µM Pb2+ to a much greater extent. Results 
obtained with 10 mM Mn2+ also reflected the same trend as Mg2+ and Cd2+ when the activity 
assays of the most perturbed PS-modified positions, 17EG14PS (kobs = 0.093 min-1), and 
17EA15PS ( kobs = 0.072 min-1) as well as unmodified 17E ( kobs = 0.086 min-1) were carried 
out (Figure 4.5a). Kinetic assays with another ‘soft’ metal ion, namely 2.5 mM Cu+, did not 
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yield any activity with 17E, 17EG14PS, or 17EA15PS. Since Cu+ may be gradually oxidized 
in water or buffer to Cu2+ over the period of the activity assay, the assays were also carried 
out with 2.5 mM Cu2+ as a control (Figure 4.5b). However, no activity was seen with either 
form of copper. Higher concentrations of Cu+ in a 10 % acetonitrile and buffer mixture led to 
significant precipitation issues and therefore could not be used. Since Zn2+ is also known as a 
‘borderline’ metal ion with regard to the HSAB theory, the kinetic assays of the most 
perturbed positions, namely 17EC9PS, 17EG14PS, and 17EA15PS, were also carried out with 
100 µM Zn2+ (the concentration at which 17E also shows activity with Zn2+ with kobs = 0.073 
min-1) and the resulting trends observed were surprisingly similar to that seen with Pb2+. The 
PS-modification at these positions caused significant perturbations and no detectable activity 
was measured after 2 hours. To ensure the similarity in the trend observed, activity assays 
were also carried out with 17ET16.2PS and 17EG7PS with 100 µM Zn2+ (these positions were 
non-perturbed with 100 µM Pb2+) and the rate constants measured were 0.064 min-1and 0.030 
min-1, respectively, with a thio effect of 1.1 and 2.4, respectively (Figure 4.5c).  
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Figure 4.4 Kinetic traces of the 17E variants containing single PS modifications on the 
enzyme strand with a) 100 µM Pb2+, b) 10 mM Cd2+, and c) 10 mM Mg2+ under single turn-
over conditions in buffer containing 50 mM MES, pH 6.0, and 100 mM NaCl.  
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Table 4.1 List of observed rate constants (kobs) for the PS modified 17E variants under 
single-turnover conditions. 
Name of the 17E 
Variant 
With 100 µM Pb2+ With 10 mM Cd2+ With 10 mM Mg2+ 
kobs     
(min-1) a 
Thio 
effect d
kobs   
(min-1) b 
Thio 
effect 
kobs      
(min-1) c 
Thio 
effect 
 Unmodified 17E 5.3  2.6 x 10-2  1.2 x 10-2  
17EG7PS 3.9 1.4 1.2 x 10-2 2.2 4.7 x 10-3 2.6 
17ET16.2PS 3.6 1.5 2.5 x 10-2 1.0 1.2 x10-2 1.0 
17EC8PS 0.25 21 2.0 x 10-2 1.3 4.7 x 10-3 2.6 
17EC3PS 0.15 35 1.3 x 10-2 2.0 3.7 x 10-3 3.2 
17EA15.0PS 0.08 66 1.1 x 10-2 2.4 3.8 x 10-3 3.2 
17EC9PS ~ 0.02 ~265 2.0 x 10-2 1.3 6.0 x 10-3 2.0 
17EG14PS N.D - 2.1 x 10-2 1.2 9.4 x 10-3 1.3 
17EA15PS N.D - 2.1 x 10-2 1.2 3.9 x 10-3 3.1 
17SG1.1PS 2.8 1.9 9.3 x 10-3 2.8 7.8 x 10-3 1.5 
17SG1.2PS 8.3 0.67 1.2 x 10-2 2.2 1.2 x 10-2 2.6 
aData shown is the mean value obtained from three trials. b, cData shown is the 
average value obtained after two trials. All the assays were carried out in 50 mM MES, pH 
6.0, and 100 mM NaCl. dThe thio effect is the ratio of the kobs of the unmodified 17E to the 
kobs value of the PS-modified variant. “N.D” denotes “not detectable” (at time intervals 
similar to activity of the unmodified 17E). 
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Figure 4.5 Kinetic traces of some of the 17E variants containing single PS modifications on 
the enzyme strand with a) 2.5 mM Cu+ in 10 % acetonitrile and 2.5 mM Cu2+ as a control in 
buffer, b) 10 mM Mn2+ and, c) 100 µM Zn2+ under single turn-over conditions in buffer 
containing 50 mM MES, pH 6.0, and 100 mM NaCl. 
4.3.4 Dependence of NMR titrations on the position of the PS modification  
Enzymes 17EG14PS and 17EA15PS containing individual PS modifications were 
chosen for 31P NMR studies based on the aforementioned kinetic gel-based activity assays, 
which indicated significant perturbation on the overall activity of these modified enzymes 
upon Pb2+ addition. The 31P NMR characterization of the enzyme and non-cleavable 
substrate complex containing a PS modification at position G7 was also performed, since the 
resulting modified enzyme showed activity that was comparable to the unmodified 17E with 
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100 µM Pb2+. The 31P NMR characterization of these modified enzymes was also carried out 
with Cd2+, which did not show any significant change in its overall kinetic activity upon PS 
modification, as reflected in the thio effect values (Table 4.1).  
 Figure 6a shows the 31P NMR spectra of the three PS-modified 17E enzymes with 
17DS (non-cleavable substrate) in the absence of any divalent metal ion. The two well-
resolved peaks of the 17EG7PS enzyme + 17DS substrate complex correspond to the two 
phosphorothioate diastereomers, RP and SP, which are in slow exchange. The 31P NMR 
spectrum of 17EG14PS + 17DS does indicate the presence of the two isomers; however, the 
peaks observed are much broader and indicate a relatively faster conformational change 
between the two isomers. In the case of 17EA15PS + 17DS, only one peak is observed 
indicating that the two isomers are undergoing rapid exchange, coalescing to the single 
feature observed. Upon temperature reduction from 25 °C to 4 °C, (Figure 4.6b) the single 
peak of 17EA15PS + 17DS at 55 ppm starts resolving into two PS features, corresponding to 
the RP and SP isomers.  
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Figure 4.6 a) 31P NMR spectra of three individual PS-modified 17E enzymes + 17DS (non-
cleavable substrate), in the absence of any divalent metal ion at 25 °C. b) Effect of 
temperature on the 31P NMR spectrum of 17EA15PS + 17DS, in the absence of any divalent 
metal ion. All measurements were carried out in 50 mM MES sodium, pH 6.0, in 10 % D2O. 
4.3.5 Effect of Pb2+ addition on the 31P NMR spectra 
Addition of increasing (0-5) equivalents of Pb2+ to the 17EG14PS + 17DS complex, 
results in an upfield shift of the PS peak (Figure 4.7a). Previous studies with ribozymes have 
indicated that metal ion addition, specifically Cd2+ addition to a PS-modified hammerhead 
ribozyme, results in a significant change in the chemical shift, moving upfield due to the 
covalency of the Cd2+-S bond. Similar experiments performed with 17EG14PS + 17DS 
resulted in upfield shifts of both PS features upon addition of Pb2+, although the change in 
the chemical shift, Δδ, is smaller in comparison with that seen at the 17EA15PS position 
(Figure 4.7b). Interestingly, upon addition of Pb2+ to 17EG7PS + 17DS, the two 
phosphorothioate peaks are shifted to a small extent, in opposite directions. The upfield peak 
shifts slightly upfield while the downfield peak shifts slightly downfield (Figure 4.7d). Such 
an observation was also made upon titration of Cd2+ into the PS-modified cleavage site of a 
minimal hammerhead ribozyme, wherein the Rp diastereomer shifted upfield, indicating 
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direct Cd2+-S binding, whereas the Sp isomer shifted downfield, thereby indicating a 
conformational change either in addition to metal binding or in place of the same. Moreover, 
Δδ for 17EG7PS + 17DS is much smaller in comparison to Δδ for 17EG14PS + 17DS and 
17EA15PS + 17DS, indicative of minimal metal interactions (Table 4.2). 
 An important control experiment was also performed wherein the 31P NMR spectrum 
of a duplex DNA strand was collected, with 17EA15PS serving as the enzyme strand and a 
“substrate strand” which was fully complementary to the enzyme strand (as opposed to the 
partially complementary 17DS). This complex was titrated with increasing equivalents of 
Pb2+. The resulting Δδ was minimal even with 5 eq. Pb2+ and was < 0.4 ppm, thereby 
indicating that the phosphorothioate modification on this duplex DNA was not a site of 
selective Pb2+-binding (Figure 4.7c). This also implied that simply having a PS modification 
on a duplex DNA did not lead to significant changes in the chemical shift upon Pb2+-
addition, rather, significant Δδ was observed only when the metal ion bound site-specifically 
to PS modifications. 
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Figure 4.7 31P NMR spectra at 25 °C of a) 17EA15PS + 17DS, b) 17EG14PS + 17DS, c) 
17EA15PS + 17E duplex control (complementary strand), and d) 17EG7PS + 17DS with 
increasing eq. (0-5) Pb2+. All measurements were made in a buffer containing 50 mM MES 
sodium, pH 6.0, in 10 % D2O. 
       
4.3.6 Effect of Cd2+ addition on the 31P NMR spectrum 
The addition of Cd2+ to the 17EA15PS + 17DS complex resulted in an upfield shift of 
the phosphorothioate peak while Cd2+ addition to 17EG14PS + 17DS resulted in upfield shifts 
of both phosphorothioate features, similar to that seen with Pb2+ addition. Addition of Cd2+ to 
17EG7PS + 17DS also results in movement of both peaks in opposite directions, as observed 
with Pb2+ (Figure 4.8a, b, d). There is, however, a clear difference in terms of the extent of 
Δδ of the upfield peak between Pb2+ and Cd2+. All three PS-modified enzymes show almost 
identical shifts upon addition of 10 equivalents of Cd2+, with the exception of the downfield 
 76 
peak of 17EG7PS, which can be attributed to either a conformational change accompanying 
metal binding as mentioned previously or due to the binding of the metal ion to the oxygen of 
a PS. On the other hand, Δδ upon Pb2+ addition is very close with 17EG14PS and 17EA15PS, 
whereas with the 17EG7PS, Δδ (upfield peak) is almost one-third smaller in comparison 
(Table 4.2 and Table 4.3). A significant broadening of the peaks is also observed. Δδ with the 
control duplex DNA is also minimal upon addition of Cd2+, again confirming that Cd2+ also 
specifically binds functional PS on the DNA backbone rather than binding solely non-
specifically to any modified PS. 
 
Figure 4.8 31P NMR spectra at 25 °C of a) 17EA15PS + 17DS, b) 17EG14PS + 17DS, c) 
17EA15PS + duplex control (complementary strand), and d) 17EG7PS + 17DS, with 
increasing eq. (0-10) Cd2+. All measurements were made in a buffer containing 50 mM MES 
sodium, pH 6.0, in 10 % D2O. 
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4.3.7 31P NMR spectra of PS modifications on the substrate strand 
The site of cleavage on the substrate strand (17S) was replaced by a non-cleavable 
deoxyriboadenosine DNA base (17DS) for all the NMR experiments as shown in Figure 
4.3b. A PS modification was also made at the “cleavage site” of 17DS, referred to as 
17DSG1.1PS. The 31P NMR spectrum of this modified enzyme-substrate complex (PS-
modified substrate complexed to unmodified 17E) showed two well-resolved peaks in the 
absence of any metal ion, indicating that the two diastereomers were undergoing a slow 
exchange at 25 °C and were conformationally locked in comparison to 17EA15PS + 17DS. 
Upon addition of 1 eq. Pb2+, both peaks shifted minimally upfield, while upon addition of 
Cd2+, there was an even smaller Δδ. Upon addition of 5 eq. Cd2+, significant broadening of 
the peaks was observed including merging of both peaks into a single peak. Upon addition of 
5 eq. Pb2+ the peaks are better resolved, though Δδ was not calculated due to the nature of the 
peaks. Nevertheless, Δδ is smaller to that seen for 17EG7PS (Figure 4.9, Table 4.2, and Table 
4.3). 
 
Figure 4.9 31P NMR spectra of 17E + 17DSG1.1PS with increasing eq. of a) Pb2+ and b) Cd2+. 
All the samples were in 50 mM MES sodium, pH 6.0, in 10 % D2O. 
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Table 4.2 Effect of Pb2+ on the 31P NMR chemical shift of 17E variants containing single PS 
modifications. 
 
Name of the 
17E Variant 
With Pb2+ 
Equiv.  
added a 
Peak 1 
(downfield 
peak) 
Peak 2 
(upfield 
peak) 
Δδ  (ppm) b 
Peak 1 Peak 2 
 
17EA15PS + 
17DS 
0 
0.5 
1 
2.5 
5 
55.38 
55.39 
55.32 
55.07 
54.36 
0 
0.01 
-0.06 
-0.31 
-1.02 
 
17EG14PS + 
17DS 
0 
0.5 
1 
2.5 
5 
55.69 
55.58 
55.70 
55.59 
55.46 
54.75 
54.64 
54.60 
54.42 
54.17 
0 
-0.11 
0.01 
-0.10 
-0.23 
0 
-0.11 
-0.15 
-0.33 
-0.58 
 
17EG7PS + 
17DS 
0 
0.5 
1 
2.5 
5 
56.01 
56.10 
56.15 
56.09 
55.93 
55.04 
55.01 
54.99 
54.84 
54.67 
0 
0.09 
0.14 
0.08 
-0.08 
0 
-0.03 
-0.05 
-0.20 
-0.37 
 
17EA15PS + 
complementary 
substrate 
0 
0.5 
2.5 
5 
54.65 
54.64 
54.57 
54.45 
54.19 
54.18 
54.12 
54.02 
0 
-0.01 
-0.08 
-0.21 
0 
-0.01 
-0.08 
-0.18 
 
17E + 
17DSG1.1PS 
0 
1 
5 
55.36 
55.15 
N. D. 
54.77 
54.56 
N. D. 
0 
-0.21 
N. D. 
 
0 
-0.21 
N. D. 
 
aThe concentration of the modified DNAzyme-substrate complex used for this study was 670 
µM in 50 mM MES sodium, pH 6.0, in 10 % D2O. A maximum of 5 eq. Pb2+ (~3.4 mM) was 
added since precipitation issues were encountered at higher concentrations. bThe direction of 
the shift is indicated as (-) for upfield and (+) for downfield. The extent of the shift is the 
difference in the peak value in the absence of Pb2+ and upon addition of different equivalents 
of Pb2+. N. D. stands for “not determined.” 
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Table 4.3 Effect of Cd2+ on the 31P NMR of 17E variants containing single PS modifications. 
 
Name of the 
17E Variant  
With Cd2+ 
Equiv.  
added a 
Peak  1 
(downfield 
peak) 
Peak 2 
(upfield 
peak) 
Δδ  (ppm) b         
  Peak 1 Peak 2        
 
17EA15PS + 
17DS 
0 
0.5 
2.5 
5 
10 
55.11 
55.12 
55.08 
54.30 
N. D 
0 
0.01 
-0.03 
-0.81 
N. D 
 
17EG14PS + 
17DS 
0 
1 
2.5 
5 
10 
55.68 
55.68 
55.62 
55.52 
55.19 
55.76 
54.38 
54.34 
54.20 
54.12 
0 
0 
-0.07 
-0.16 
-0.49 
0 
-0.38 
-0.41 
-0.56 
-0.64 
 
17EG7PS + 
17DS 
0 
1 
2.5 
5 
10 
55.86 
55.99 
56.13 
56.18 
56.20 
54.66 
54.64 
54.59 
54.34 
54.11 
0 
0.13 
0.27 
0.32 
0.33 
0 
-0.02 
-0.07 
-0.32 
-0.55 
 
17EA15PS + 
complementary 
substrate 
0 
0.5 
2.5 
5 
54.66 
54.65 
54.63 
54.58 
54.20 
54.20 
54.19 
54.14 
0 
-0.01 
-0.03 
-0.08 
0 
0.00 
-0.02 
-0.06 
 
17E + 
17DSG1.1PS 
0 
1 
5 
 
55.35 
55.20 
N. D. 
 
54.76 
54.64 
N. D. 
 
0 
-0.14 
N. D. 
 
0 
-0.12 
N. D. 
 
 
aThe concentration of the modified DNAzyme-substrate complex used for this study was 670 
µM in 50 mM MES sodium, pH 6.0, in 10 % D2O. A maximum of 10 equivalents of Cd2+ 
(~6.7 mM) was used as significant broadening issues were encountered at this concentration. 
bThe direction of the shift is indicated as (-) for upfield and (+) for downfield. The extent of 
the change in shift (Δδ) is the difference in the peak value in the absence of Cd2+ and upon 
addition of different eq. Cd2+. N. D. stands for “not determined.” 
4.4 Discussion 
While significant efforts have been made in determining the role of the metal ions 
responsible for activity in the 8-17 DNAzyme, identifying binding sites on the actual 
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enzyme-substrate complex has been a challenge, particularly in the absence of either an X-
ray crystal structure or an NMR structure for the 8-17 DNAzyme. Even more challenging is 
the fact that the most effective co-factor of this DNAzyme is Pb2+, which is a 
spectroscopically silent metal ion. Hence, characterization techniques such as UV-Vis and 
EPR, which are routinely used to identify metal ion binding sites of metalloproteins, are very 
challenging to use without prior modifications. The use of PS modifications on the phosphate 
backbone of nucleic acid enzymes, therefore, is a simple but effective technique that has been 
extensively utilized to identify and confirm potential metal ion binding sites of various 
ribozymes as discussed previously. The results obtained in the current study reveal the roles 
that phosphates play in metal ion binding, particularly with Pb2+, and providing a snapshot of 
a potential ‘active metal ion binding site’. 
4.4.1 Effect of PS modifications on AGC terminal loop 
Table 1 shows that under single-turnover conditions, the effect of PS modifications 
(17EG7PS, 17EC8PS, and 17EC9PS) on the overall kobs values in the presence of 100 µM 
Pb2+ varies with the position of the modification. Interestingly, this thio effect with Pb2+ 
follows the order: G7 < C8 < C9, with kobs for G7 virtually unchanged in comparison with the 
unmodified enzyme, while kobs for C8 was lowered by an order of magnitude and kobs for C9 
was lowered by two orders of magnitude upon PS modification. The original in vitro 
selection study on the 8-17 DNAzyme has indicated that bases A6, G7, and C8 on the terminal 
loop are strictly conserved and are critical for the function of the DNAzyme.58 Mutagenesis 
studies have also indicated that any mutations on this loop result in a > 50-fold loss in 
catalytic activity.1-3,5 
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 Bases A6 and G7 are thought to be involved in close interaction with other portions of 
the enzyme-substrate complex through hydrogen-bond interactions; any replacement by 
bases or base analogues leads to a significant decrease in catalytic activity.59,57 Mutations on 
residue C8, on the other hand, led to a five- to ten-fold decrease in the overall catalytic 
activity. Cross-linking studies have indicated that the contact point of the AGC loop is the 
actual cleavage site of the substrate rather than any other portion of the enzyme-substrate 
complex including the bulge loop or the helical stem.6 Folding studies have also indicated 
that bases A6 and G7 are important elements for the overall folding of the 8-17 DNAzyme.54 
PS modification of the G7 residue results in a reversed trend of activity compared with base 
analog mutations; base modifications to A6 result in large decreases in activity, whereas PS 
modification of G7 is relatively inconsequential. This result reinforces the importance of A6 
in the hydrogen bonding network and shows that the backbone between A6 and G7 is 
participating in weak metal ion binding at best, as indicated by a reduction in kobs by an order 
of magnitude upon PS modification at G7. The thio effect of ~265, in the case of PS-modified 
C9, suggests that the phosphate backbone of this particular residue is likely to be involved in 
selective Pb2+-binding.  
Our current studies lead us to believe that bases A6 and G7 do indeed perform an 
important role in the overall structure adopted by the 8-17 DNAzyme. These bases are 
necessary for structure formation rather than direct involvement in metal ion-binding. The 
phosphate backbone at position C9, on the other hand, seems to be important for Pb2+ binding 
and activity of the DNAzyme. Interestingly, the thio effect values obtained with both 10 mM 
Cd2+ and 10 mM Mg2+ suggest that the binding of these metal ions to any of these three 
phosphates is not functionally important. Instead, it could be postulated that binding of these 
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metal ions to the PS-modified positions is not responsible for activity or that there is no 
specific binding at all. Rather, the presence of either Mg2+ or Cd2+ facilitates the formation of 
an active structure, before catalysis can take place, and stabilizes the structure via 
electrostatic interactions. 
4.4.2 Effect of PS modifications at bases on the TCGAA loop 
Single PS modifications at positions G14 and A15 (Table 4.1) resulted in a significant 
loss in the catalytic activity of the 8-17 DNAzyme with 100 µM Pb2+. In fact, the kobs values 
of the PS-modified enzymes with 100 µM Pb2+ could not be estimated during the course of 
one hour, while the kobs for the unmodified 17E enzyme is calculated to be ~ 5.3 min-1 under 
identical conditions. This significant difference in activity suggests that the phosphate groups 
of these bases play an essential role in the catalytic activity of the 8-17 DNAzyme, with 
implications for metal ion binding, specifically with either Pb2+ or Zn2+ (since Zn2+ also 
exhibits similar behavior relative to the unmodified enzyme).  
Previous mutagenesis studies have indicated that replacement of the C13 base by a 5-
bromo cytosine residue resulted in only a four-fold drop in activity as compared to a forty-
fold drop in activity as expected for a cytosine group that performed a general acid-base 
catalyst role at neutral pH.5 This excluded the role of this base as a general acid-base catalyst. 
Replacement of the G14 base by other base analogues suggested the importance of the 2-
amino group for activity. When these mutant G14 enzymes were tested with various metal 
ions, however, there was no preference for any metal ion, suggesting that G14 did not bind to 
any crucial metal ion. Also, while the functional importance of the 2-amino group of G14 was 
observed, there was no clear evidence for a direct involvement of the base in catalysis.5 Our 
results, however, suggest that the phosphate groups 5′ of both G14 and A15 do indeed show a 
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significant preference in terms of activity with different metal ions, thereby indicating that 
the nucleotide itself is not involved in metal ion binding. Rather, the phosphate group of the 
base is involved in metal ion binding, specifically binding with Pb2+ and Zn2+.  
4.4.3 Effect of PS modifications on the substrate strand 
A PS modification at the cleavage site led to a small thio effect, ca. 2, with Pb2+. This 
result is rather interesting and points to the previously proposed idea that Pb2+ might not 
directly coordinate to the phosphate oxygen on the RNA base during catalysis.2 Rather, it 
affects catalysis by acting as a Lewis base and abstracting a proton from the –OH group, 
owing to its low metal hydrate pKa value of 7.8. Moreover, a metal binding site for Pb2+ was 
also thought to contribute to its high activity, which is strengthened by the current 
observations. Interestingly, a PS replacement 5′ of G1.2 (between G1.2 and G1.1 of the wobble 
pair) led to a small increase in kobs and a thio effect of <1 with Pb2+. The G1.1 base is a part of 
the G·T wobble pair that has been shown previously to be critical for activity of the 8-17 
DNAzyme.9,2,4,5 Moreover, recent studies by Sen and co-workers have indicated that the role 
of this wobble pair could be structural, by helping in maintaining the required orientation of 
the catalytically active nucleotides around the active site.6 Strong cross-links between the 
G1.1 base on the substrate as well as the G14 base on the enzyme strand have also been 
observed.6 The results presented here do not support Pb2+ binding to the backbone either 5′ or 
3′ of the G·T wobble pair, 5′ being the site of cleavage. 
4.4.4 31P NMR studies of the 8-17 DNAzyme 
31P NMR investigations of the modified 8-17 DNAzymes, 17EG7PS, 17EG14PS, and 
17EA15PS have been carried out with both Pb2+ and Cd2+. These locations were chosen for 
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NMR study based on their different activities in the kinetic activity assay studies. It should be 
noted that a racemic mixture, namely RP and SP about the phosphorous center, was used in 
this work. The primary aim of this study was to identify functional phosphates involved in 
metal ion binding, rather than the specific spatial arrangement of the ligands bound to the 
metal ion. This will be, however, attempted in the future. As a racemic mixture was used, 
most of the modified enzyme-substrate complexes studied herein by 31P NMR have shown 
distinct separation of the two diastereomers formed upon a single PS modification on the 
phosphate, as indicated by two peaks in the NMR spectrum. 
An exception to the separation noted above, the 31P NMR spectrum of 17EA15PS 
shows only a single peak in the absence of any divalent metal ions, indicating the 
conformational flexibility of this site and the fast exchange of the two diastereomers RP and 
SP. The addition of either Pb2+ or Cd2+ results in a significant Δδ and also broadens the single 
peak, indicating that metal ion binding takes place in a selective manner as confirmed by the 
large Δδ in comparison to control samples (Figure 4.7a and Figure 4.8a). As noted from 
activity assays, Pb2+ binding at 17EA15PS is related to activity, whereas Cd2+ binding is non-
specific. This difference in behavior between metal ions is confirmed by the 31P NMR 
spectrum of 17EA15PS with a fully complementary DNA strand (Figure 4.3c) in place of the 
substrate strand (17DS). The complex in the absence of divalent metal ions shows two 
distinct peaks and Pb2+ addition results in Δδ ca. 0.2 ppm for both, compared with Δδ ca. 1.0 
ppm seen with 17EA15PS and 17DS. Binding of Cd2+ to 17EA15PS with the fully 
complementary substrate also results in a measurable Δδ for each peak; however, the extent 
of the shift is roughly half that seen with 17EA15PS and 17DS (compared to 1/5th for Pb2+) 
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indicating Cd2+ non-specific binding. Therefore, Pb2+ is binding to 17EA15PS and is 
functional for activity, while Cd2+ binding is present, though non-essential for function. 
 In the absence of any metal ion the 31P NMR spectra of both 17EG14PS and 
17EG7PS, both with 17DS, appear to be conformationally restrained and are resolved into the 
two diastereomers, RP and SP. Upon addition of either Pb2+ or Cd2+ ions to 17EG14PS + 
17DS, there is a significant Δδ of both the peaks (Table 4.2 and Table 4.3). In comparison 
with the highly perturbed A15PS and G14PS sites, Δδ for the G7PS modified enzyme is much 
lower with Pb2+; the downfield peak barely moving with increasing eq. Pb2+ while the upfield 
peak moved to a greater extent (Δδ=0.37 ppm). In contrast, Δδ of the G7PS modified enzyme 
with Cd2+ is significant for the upfield peak, similar to that seen in the G14PS modified 
enzyme. This Δδ shows lack of preference of Cd2+ towards the position of the phosphate in 
comparison with Pb2+, which exhibits more specific binding to particular phosphates.  
The relatively small Δδ (>0.4 ppm) of the PS-modified substrate strand, 17DSG1.1PS 
with unmodified 17E, in the presence of both Pb2+ and Cd2+, suggests that the phosphates at 
this position are much less likely involved in direct metal ion binding. This observation 
further confirms the idea that the Pb2+ ion might affect catalysis by acting as a Lewis base 
with site-specific binding rather than direct coordination at the phosphate group of the 
cleavable substrate. Insights obtained from photo cross-linking studies indicated that there 
are three major contacts seen between the two nucleotides flanking the scissile 
phosphodiester site of the substrate and the DNAzyme strand: firstly, with the DNAzyme’s 
T2.1 residue, which is a part of the functionally important G1.1·T2.1 wobble pair, secondly with 
C13, G14 and A15 of the WCGAA bulge loop, and finally weak contacts with the A6 residue of 
the AGC terminal loop.6 The role of T17.1 has not been implicated as important for function. 
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Hence, these combined results suggest an extremely important role for the bases in proximity 
to the cleavage site, both in sequence and structure, as well as functional phosphates in 
selected positions of the enzyme strand. Phosphates on the substrate strand may be important 
in maintaining the active site structure, though metal ion binding is non-specific in nature. 
4.4.5 Implications for metal ion binding and activity 
This study implicates several phosphates in the catalytic core as forming a specific 
metal-binding pocket for Pb2+, thereby facilitating activity. Based on the previously 
discussed results, these phosphates are 5′ of C9, G14, and A15 on the enzyme strand. 
Importantly, our current kinetic studies have been carried out with racemic mixtures of the 
PS-modified oligonucleotides, and hence, we cannot distinguish binding between the two 
phosphate stereoisomers, namely pro-RP and pro-SP, as is shown in Figure 4.10. Hence, Pb2+ 
binding to either of the two stereoisomeric oxygens might be envisioned. The active-site 
binding pocket may be responsible for the efficient catalysis of the 8-17 DNAzyme observed 
in the presence of Pb2+. It is interesting to note that Zn2+ perturbs the C9PS, G14PS, and A15PS 
modifications as does Pb2+, implying that these phosphates also play an important role in 
facilitating Zn2+ activity. Though Pb2+ and Zn2+ interact with the same phosphate residues, 
recent unpublished results based on 1H NMR studies provided additional support for minimal 
local structural rearrangement in the presence of Pb2+, though significant rearrangement was 
seen in the presence of Zn2+. Hence, the 8-17 DNAzyme exhibits a lowered activity for Zn2+ 
in comparison with Pb2+; however it is still higher than all the other divalent metal-ion 
cofactors. Previous studies have shown that sequence-variations of the 8-17 DNAzyme seem 
to affect the activities of different metal ions (including Ca2+, Mg2+, Pb2+, and Zn2+) in a 
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similar manner, suggesting that the specificity of the sequence is independent of the metal 
ions used in the reaction.5 
 On the other hand, it has been proposed that there are multiple reaction pathways 
depending on the nature of metal ion used.12,13,16 Since the reaction pathway of the 8-17 
DNAzyme in the presence of Pb2+ does not involve folding before cleavage activity, it is 
thought that the DNAzyme maybe prearranged to accept Pb2+ and may have a ligand binding 
pocket, like that seen with the GlmS or the group I ribozyme.60,31,16 Moreover, since the 
folding behavior with Pb2+ is in contrast with that observed with Zn2+ and Mg2+ it is also 
thought that Pb2+ could occupy a binding site different from these metal ions, or bind to a 
similar site, but with a different mode such that no significant global conformational change 
occurs. Our current kinetic assays in the presence of Pb2+ coupled with the 31P NMR data 
suggest that the phosphates at the PS-modified positions are part of an active-site binding 
pocket that evolved through the artificial ‘directed evolution’ process. Since activity is not 
significantly affected upon PS modification of the substrate arm, and no specific binding is 
seen based on 31P NMR, the substrate is likely not involved in metal ion binding. Rather, G1.1 
plays an important role in maintaining active-site contacts with the other conserved bases. 
Our kinetic results suggest that Zn2+ binding may take place at the same active-site, but as 
indicated by the FRET studies the mechanism is different. A folding step (for easy access to 
the active-site or to cross a potential energy barrier) prior to the active-site binding step is 
necessary, thereby leading to the lowered activity of the 8-17 DNAzyme complex for Zn2+ in 
comparison with Pb2+. Also, a two-step mechanism for the 8-17 DNAzyme has been 
demonstrated with Pb2+ (only a single step takes place with Zn2+ and Mg2+) and it has been 
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proposed that to complete this two-step mechanism, a specific, three-dimensional structure 
that forms a Pb2+-binding site may be required,2 further adding value to our current results. 
The NMR studies presented here indicate that binding to the PS-modified strands 
does occur in the presence of Cd2+. This occurs, however, at all PS-modified positions 
studied, indicating the lack of specificity for a particular site. Kinetic studies further suggest 
that the PS modifications do not affect the overall activity of the 8-17DNAzyme in the 
presence of either Mg2+ or Cd2+, implying that these metal ions form, at best, weak contacts 
with the phosphates at these positions, and metal ion binding here may not be crucial for 
activity of the enzyme.  
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Figure 4.10 Proposed Pb2+ binding site in the 8-17 DNAzyme based on PS modifications and 
31P NMR. The bases shown in green refer to the most perturbed bases on the enzyme strand, 
while the X represents a hydrated Pb2+-complex. Based on our current kinetic studies with 
racemic mixtures of PS-modified oligonucleotides, it is envisioned that Pb2+ might bind 
either of the two stereo-isomeric oxygens of the phosphates, namely either pro-RP or pro-SP. 
4.5 Conclusions 
In the current study, the role of phosphates in catalysis carried out by the 8-17 
DNAzyme has been investigated through the systematic replacement of single P-O bonds on 
the phosphate backbone by PS modifications on conserved bases shown previously to be 
important based on mutational and cross-linking studies. We have also used 31P NMR to 
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directly observe metal ion binding toward PS modifications. Phosphates adjacent to bases 
that were previously identified as important sites in the catalytic core of the 8-17 DNAzyme 
were chosen for replacement with individual P-S bonds in place of P-O bonds, and the 
resulting enzymes were tested with different metal ions. These metal ions included the most 
effective co-factor of the DNAzyme, Pb2+, the borderline hard/soft Zn2+ ion (which exhibits 
moderate activity) as well as soft metal ions such as Cd2+, Mn2+, and Cu+ as well as the hard 
Mg2+ ion (which exhibits activity, though lower than Zn2+). Cu2+ was used a control for the 
Cu+ experiments. In kinetic assays, some of the PS-modified enzymes studied were perturbed 
significantly over the unmodified enzyme in the presence of 100 µM Pb2+ and Zn2+, thereby 
suggesting the importance of the phosphates at these positions for metal-binding. No 
significant differences in terms of activity of the PS-modified 17E DNAzyme over the 
unmodified enzyme have been observed with other metal ions including Cd2+, Mg2+, Mn2+, 
Cu2+, and Cu+, suggesting no specific preference for enzyme strand phosphates. A PS 
modification on the substrate strand at the cleavage site resulted in a small change in the 
observed rate, while a modification 5′ of the G1.2 (adjacent to the G·T wobble pair) resulted 
in a slightly higher activity with Pb2+ compared to the unmodified substrate. Also, 31P NMR 
spectra of 17DSG1.1PS + 17E did not show a significant Δδ upon Pb2+ addition and relatively 
minimal Δδ with Cd2+. This suggested that binding of the metal ion to the phosphate of the 
cleavable RNA base was not crucial for activity; rather a role of Pb2+ as a Lewis base for 
facilitating hydrolysis was implicated, while the 17SG1.2PS modification implied structural 
importance of the wobble pair in maintaining the active site orientation, rather than in metal 
ion binding. 
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We have demonstrated the use of phosphorothioate modifications to identify 
functional phosphates of the 8-17 DNAzyme that are likely involved in metal ion binding. 
31P NMR has been used as an additional tool to directly visualize the backbone phosphates 
and their interactions with metal ions. These results, in conjunction with those previously 
established, have led to the identification of a proposed Pb2+ -binding site for the 8-17 
DNAzyme and the first conclusive evidence that the conserved bases are important for 
maintaining the active structure while metal ion binding takes place primarily on the 
backbone rather than on the conserved bases. 
4.6 References    
(1) Peracchi, A. J. Biol. Chem. 2000, 275, 11693. 
(2) Brown, A. K.; Li, J.; Pavot, C. M.; Lu, Y. Biochemistry 2003, 42, 7152. 
(3) Bonaccio, M.; Credali, A.; Peracchi, A. Nucleic Acids Res. 2004, 32, 916. 
(4) Cruz, R. P.; Withers, J. B.; Li, Y. Chem. Biol. 2004, 11, 57. 
(5) Peracchi, A.; Bonaccio, M.; Clerici, M. J. Mol. Biol. 2005, 352, 783. 
(6) Liu, Y.; Sen, D. J. Mol. Biol. 2008, 381, 845. 
(7) Schlosser, K.; Gu, J.; Sule, L.; Li, Y. Nucleic Acids Res. 2008, 36, 1472. 
(8) Li, J.; Zheng, W.; Kwon, A. H.; Lu, Y. Nucleic Acids Res. 2000, 28, 481. 
(9) Santoro, S. W.; Joyce, G. F. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 4262. 
(10) Liu, Y.; Sen, D. J. Mol. Biol. 2010, 395, 234. 
(11) Sekhon, G. S.; Sen, D. Biochemistry 2010, 49, 9072. 
(12) Kim, H. K.; Liu, J.; Li, J.; Nagraj, N.; Li, M.; Pavot, C. M.; Lu, Y. J. Am. Chem. Soc. 
2007, 129, 6896. 
(13) Kim, H. K.; Rasnik, I.; Liu, J.; Ha, T.; Lu, Y. Nat. Chem. Biol. 2007, 3, 763. 
(14) Lam, J. C. F.; Li, Y. ChemBioChem 2010, 11, 1710. 
(15) Wang, B.; Cao, L.; Chiuman, W.; Li, Y.; Xi, Z. Biochemistry 2010, 49, 7553. 
(16) Mazumdar, D.; Nagraj, N.; Kim, H. K.; Meng, X.; Brown, A. K.; Sun, Q.; Li, W.; Lu, 
Y. J. Am. Chem. Soc. 2009, 131, 5506. 
(17) Matzura, H.; Eckstein, F. Eur. J. Biochem. 1968, 3, 448. 
(18) Eckstein, F. J. Am. Chem. Soc. 1970, 92, 4718. 
(19) Herschlag, D.; Piccirilli, J. A.; Cech, T. R. Biochemistry 1991, 30, 4844. 
(20) Oivanen, M.; Ora, M.; Almer, H.; Stromberg, R.; Lönnberg, H. J. Org. Chem. 1995, 
60, 5620. 
(21) Ora, M.; Oivanen, M.; Lönnberg, H. J. Org. Chem. 1996, 61, 3951. 
(22) Frey, P. A.; Sammons, R. D. Science 1985, 228, 541. 
(23) Liang, C.; Allen, L. C. J. Am. Chem. Soc. 1987, 109, 6449. 
(24) Eckstein, F. Phosphorus Chem.Directed Biol., Lect. Int. Symp. 1980, 125. 
 92 
(25) Eckstein, F. ACS Symp. Ser. 1981, 171, 99. 
(26) Eckstein, F. Annu. Rev. Biochem. 1985, 54, 367. 
(27) Olsen, D. B.; Sayers, J. R.; Kotzorek, G.; Eckstein, F. Nucleosides Nucleotides 1991, 
10, 665. 
(28) Eckstein, F. Biochimie 2002, 84, 841. 
(29) Basu, S.; Strobel, S. A. RNA 1999, 5, 1399. 
(30) Hunsicker, L. M.; DeRose, V. J. J. Inorg. Biochem. 2000, 80, 271. 
(31) Cernak, P.; Madix, R. A.; Kuo, L. Y.; Lehman, N. J. Inorg. Biochem. 2008, 102, 
1495. 
(32) Pearson, R. G. J. Chem. Educ. 1968, 45, 581. 
(33) Herschlag, D.; Khosla, M. Biochemistry 1994, 33, 5291. 
(34) Pyle, A. M. Nucleic Acids Mol. Biol. 1996, 10, 75. 
(35) Lambowitz, A. M.; Caprara, M. G.; Zimmerly, S.; Perlman, P. S. Cold Spring Harbor 
Monogr.Ser. 1999, 37, 451. 
(36) Crary, S. M.; Kurz, J. C.; Fierke, C. A. RNA 2002, 8, 933. 
(37) Sun, L.; Harris, M. E. RNA 2007, 13, 1505. 
(38) Ruffner, D. E.; Uhlenbeck, O. C. Nucleic Acids Res. 1990, 18, 6025. 
(39) Kumar, P. K. R.; Zhou, D. M.; Yoshinari, K.; Taira, K. Nucleic Acids Mol. Biol. 
1996, 10, 217. 
(40) Knoll, R.; Bald, R.; Furste, J. P. RNA 1997, 3, 132. 
(41) Peracchi, A.; Beigelman, L.; Scott, E. C.; Uhlenbeck, O. C.; Herschlag, D. J. Biol. 
Chem. 1997, 272, 26822. 
(42) Horton, T. E.; Maderia, M.; DeRose, V. J. Biochemistry 2000, 39, 8201. 
(43) Maderia, M.; Horton, T. E.; DeRose, V. J. Biochemistry 2000, 39, 8193. 
(44) Maderia, M.; Hunsicker, L. M.; DeRose, V. J. Biochemistry 2000, 39, 12113. 
(45) Osborne, E. M.; Schaak, J. E.; Derose, V. J. RNA 2005, 11, 187. 
(46) Osborne, E. M.; Ward, W. L.; Ruehle, M. Z.; DeRose, V. J. Biochemistry 2009, 48, 
10654. 
(47) Zhou, D.-M.; Kumar, P. K. R.; Zhang, L.-H.; Taira, K. J. Am. Chem. Soc. 1996, 118, 
8969. 
(48) Scott, E. C.; Uhlenbeck, O. C. Nucleic Acids Res. 1999, 27, 479. 
(49) Suzumura, K.; Takagi, Y.; Orita, M.; Taira, K. J. Am. Chem. Soc. 2004, 126, 15504. 
(50) Horton, T. E.; Clardy, D. R.; DeRose, V. J. Biochemistry 1998, 37, 18094. 
(51) Morrissey, S. R.; Horton, T. E.; DeRose, V. J. J. Am. Chem. Soc. 2000, 122, 3473. 
(52) Vogt, M.; Lahiri, S.; Hoogstraten, C. G.; Britt, R. D.; DeRose, V. J. J. Am. Chem. 
Soc. 2006, 128, 16764. 
(53) Nawrot, B.; Widera, K.; Wojcik, M.; Rebowska, B.; Nowak, G.; Stec, W. J. FEBS J. 
2007, 274, 1062. 
(54) Lee, N. K.; Koh, H. R.; Han, K. Y.; Kim, S. K. J. Am. Chem. Soc. 2007, 129, 15526. 
(55) Kim, H. K.; Li, J.; Nagraj, N.; Lu, Y. Chem. Eur. J. 2008, 14, 8696. 
(56) Nowakowski, J.; Shim, P. J.; Prasad, G. S.; Stout, C. D.; Joyce, G. F. Nat. Struct. 
Biol. 1999, 6, 151. 
(57) Peracchi, A.; Bonaccio, M.; Clerici, M. J. Mol. Biol. 2005, 352, 783. 
(58) Faulhammer, D.; Famulok, M. J. Mol. Biol. 1997, 269, 188. 
(59) Brown, A. K.; Li, J.; Pavot, C. M.-B.; Lu, Y. Biochemistry 2003, 42, 7152. 
(60) Lim, J.; Grove, B. C.; Roth, A.; Breaker, R. R. Angew. Chem. Int. Ed. 2006, 45, 6689. 
93 
 
5 Generation of a Red Pb2+ Species from a Phosphorothioate Modified 8-
17 DNAzyme 
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5.1 Introduction 
5.1.1 The 8-17 DNAzyme and metal ion cofactors 
DNAzymes are catalytic DNA molecules, obtained through in vitro selection, capable 
of performing a variety of reactions.1-4 The most studied DNAzyme, the 8-17 DNAzyme, 
was isolated under various conditions by several groups.5-9 This DNAzyme cleaves a 
substrate strand composed of RNA, or DNA with a single ribonucleotide, in the presence of 
certain divalent metal ions. Several surveys of metal ion-dependent activity have been 
performed and this DNAzyme was found to display highest activity with Pb2+, though none 
of the initial selections contained Pb2+.10,11 Utility of the 8-17 DNAzyme has been 
demonstrated by conversion into numerous sensitive and selective sensors with various 
methods of detection, 12-18 though the metal ion cofactor binding properties remain poorly 
understood. Several biochemical10,19-23 and biophysical24-30 studies have enhanced 
understanding, though the ligand set remains unknown. 
5.1.2 Use of phosphorothioate modified DNA and RNA to study metal ion binding and 
cleavage behavior 
Metal ion interactions with DNA and RNA are common, resulting in charge 
neutralization through the presence of K+, Na+, and Mg2+. Metal ion localization may also be 
specific in nature, enabling complex structure formation and/or catalytic activity.4 Presence 
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of metal ions can be confirmed by X-ray or NMR structure determination, though both 
methods are very time consuming and technically difficult. Demonstration of specific 
interaction is not always possible on the basis of structure alone as presence does not prove 
involvement in catalysis. In terms of catalysis, divalent metal ions are more important for 
activity than monovalent.2 Unfortunately Mg2+ does not provide a convenient spectroscopic 
handle for investigation of interaction and may be termed ‘spectroscopically silent.’ 
Replacement with a different divalent metal ion such as the EPR active Mn2+ may be 
necessary. It should be noted that all populations will be observed simultaneously by 
spectroscopic techniques31 so some way of distinguishing between signals for different 
environments is necessary. 
Metal ion interactions with DNA and RNA can be explained in part by the hard soft 
acid base theory (HSAB) of Pearson.32 In general, “hard” metal ions prefer “hard” ligands 
and “soft” metal ions prefer “soft” ligands. Mg2+ often binds to “hard” oxygen, though if 
oxygen is replaced with “soft” sulfur, the affinity of Mg2+ for a given site will decrease. The 
backbone of DNA is a phosphodiester backbone, consisting of two bridging and two non-
bridging oxygen atoms, any of which can be replaced by sulfur. Replacement of bridging 
oxygen atoms results in a phosphorothiolate mutation as shown in Figure 5.1. 
Phosphorothiolates, which may also be referred to as bridging phosphorothioates, are much 
less stable compared to phosphodiester linkages, particularly in the presence of divalent 
metal ions.33 
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Figure 5.1 Phosphorothiolate (left) and phosphorothioate (right) modifications showing 
mutation of bridging oxygen to sulfur and non-bridging oxygen to sulfur, respectively. Bases 
are indicated by “B.” Phosphorothiolate modifications may be either 5′ or 3′ in nature (3′ is 
shown). Phosphorothioate modification results in a stereocenter designated Rp or Sp. 
Replacement of non-bridging oxygen with sulfur generates a phosphorothioate, a 
modification present in nature.34 Both phosphorothioates and phosphorothiolates can be 
considered isostructural mutations, though there is some disagreement about structural 
perturbations from phosphorothioate mutations.35 Nevertheless, the intrinsic reactivity of 
oxygen and sulfur in phosphorothioates is known to be similar, making phosphorothioates 
useful in determining metal ion interactions.36 Activity of a ribozyme or DNAzyme with both 
unmodified and phosphorothioate-modified positions on the backbone can be compared in 
the presence of M2+. In general, the substrate strand is 32P-labeled on the 5′ end, the reaction 
is initiated by M2+ addition, quenched at several time points, followed by separation of 
cleaved fragments by gel electrophoresis and quantification using a phosphorimager. A drop 
in activity with Mg2+ upon mutation to a phosphorothioate is indicative of Mg2+ interaction. 
Activity may also be “rescued” by addition of a thiophilic or metal ion such as Mn2+ or Cd2+.  
Complementary to activity assays, NMR may be used to investigate metal ion 
interaction with phosphorothioate modified DNA or RNA. In 31P NMR, the DNA backbone 
signal is located at ca. 0 ppm. Upon mutation to a phosphorothioate, the 31P NMR signal of 
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the phosphorous atom bound to sulfur is shifted downfield over 50 ppm, leading to a very 
large separation from the rest of the backbone and a signal with known origin (it can 
correspond only to the mutation inserted by chemical synthesis). Metal ion interactions can 
be followed by noting any change in the chemical shift of this peak upon metal ion addition. 
Comparison between hard and soft metal ions may be made, analogous to activity assay 
experiments. 
5.1.3 Serendipity strikes: Discovery of a red DNA-Pb2+ species 
In the course of phosphorothioate modification studies of the 8-17 DNAzyme, the 
backbone at the cleavage site was mutated to a phosphorothioate and Pb2+ was added, 
followed by monitoring of the phosphorothioate resonance by 31P NMR. Normally an 
inactive construct is used for NMR studies with the ribonucleotide at the cleavage site 
replaced with a deoxyribonucleotide rendering the ribozyme or DNAzyme inactive.37-42  In 
practice RNA-cleaving DNAzymes consist of separate enzyme and substrate strands and 
cleavage of the substrate strand would result in dissociation of the substrate strand and loss of 
the catalytic conformation. In this particular experiment the replacement was not made and 
therefore the DNAzyme remained active. Upon removal of the sample from the instrument 
several hours later, a red color was noted as shown below in Figure 5.2. To our knowledge, 
colored DNA species are very rare without addition of a flourophore or other moiety. In 
addition, though many studies have used phosphorothioate modifications,43 including one on 
the 10-23 DNAzyme44 and several on the hammerhead ribozyme,45,39  none to our knowledge 
have noted a color change. This is not surprising as the color seen here occurred at high 
concentration, much beyond the range of activity assays, and most studies to date have 
investigated Mg2+ behavior, not Pb2+ behavior. Colored Pb2+ species in general are unusual, 
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seldom reported, or a combination of both. A red colored lead compound, Pb3O4, known as 
red lead has been available since antiquity.46 It is however practically insoluble in water 
unlike the species reported here. 
 
                                    
Figure 5.2 Photograph of an NMR sample containing 670 µM each 17SrAPS and 17E in 50 
mM MES sodium, pH 6, with 5 eq. Pb2+ relative to 17SrAPS, taken ca. 3 hours after Pb2+ 
addition (left) and the secondary structure of the 8-17 DNAzyme indicating the 
phosphorothioate modification at the cleavage site (right). 
5.1.4 Cleavage mechanism of the 8-17 DNAzyme 
Cleavage of the substrate strand by the 8-17 DNAzyme is made possible by select 
divalent metal ions, with Pb2+ demonstrating the highest activity followed by Zn2+ and 
Mg2+.10 The cleavage mechanism presumably involves deprotonation of the 2′-OH of the 
single ribonucleotide at the cleavage site, resulting in an attack on phosphorous and 
separation into two strands via an inline geometry. The cleavage products are well 
characterized: the 5′ half of the substrate strand ends in a cyclic phosphate forming cyclic 
Product 1 (cP1), which may be hydrolyzed in the presence of Pb2+, but not other metal ions, 
to a 2′ or 3′ phosphate, forming Product 1 (P1). The 3′ half of the substrate leaves with a 5′-
OH, forming Product 2 (P2), as shown in Figure 5.3.47 
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Figure 5.3 Cleavage mechanism of the 8-17 DNAzyme showing cleavage of the substrate 
strand to form cyclic Product 1 (which may be hydrolyzed in the presence of Pb2+ to Product 
1) and Product 2. Cations are removed for clarity. 
 As phosphorothioates are considered to be an isostructural mutation, the cleavage 
mechanism is not expected to change upon modification,48 though stability of the products 
may change, including susceptibility to hydrolysis. 
5.1.5 Examples of sulfur-M2+ charge transfer bands 
A spectroscopic study of interaction between Pb2+ and DNA has been undertaken and 
no significant spectral change was noted.49 As the red color is not present with wild type 8-17 
and Pb2+, and only arose upon phosphorothioate modification at the cleavage site, it is 
prudent to consider examples of Pb2+ charge transfer in other systems containing Pb2+ and 
sulfur. There have been several studies with both non-selective50 and selective Pb2+ binding 
proteins.51,52 A distinct absorbance was noted at 337 nm which showed the involvement of 
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Cys residues.52 To our knowledge no examples of Pb2+ charge transfer with nucleic acids 
exist, though one example of M2+-sulfur charge transfer in nucleic acids with Hg2+ has been 
reported.48 Interaction of Hg2+ with the hammerhead ribozyme, which was phosphorothioate 
modified at the cleavage site, resulted in an increased absorbance at 350 nm and provided 
evidence for inner-sphere coordination of Hg2+. The charge transfer noted was under 
conditions were the ribozyme remained inactive.48 
5.2 Materials and Methods 
5.2.1 Materials 
HPLC purified phosphorodithioate modified DNA was obtained from AM 
Biotechnologies, LLC, Houston, TX. All other oligonucleotides were obtained desalted from 
Integrated DNA Technologies Inc. (Coralville, IA) and were purified as necessary by 
polyacrylamide gel electrophoresis (PAGE). Oligonucleotides containing phosphorothioate 
modifications were obtained as racemic mixtures, containing both the RP and SP 
stereoisomers, and were used without any chiral separation. All metal salts used were 
obtained from Alfa-Aesar (Ward Hill, MA) and were of Puratronic® grade, 99.999 %. [γ-
32P]- adenosine 5′-triphosphate (ATP) was obtained from PerkinElmer, Inc. (Waltham, MA) 
and T4 kinase was obtained from Invitrogen/Life Technologies (Carlsbad, CA), or New 
England Biolabs, Inc., (Ipswich, MA). 
Adenosine 3′,5′-cyclic monophosphorothioate salts (Rp- and Sp-isomers) were 
obtained from Sigma-Aldrich Co. (St. Louis, MO). Adenosine 2′,3′-cyclic 
monophosphorothioate salts (Rp- and Sp-isomers) were obtained from BIOLOG Life Science 
Institute (Bremen, Germany), via Axxora, LLC (San Diego, CA). All other chemicals were 
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of at least ACS reagent grade and were purchased from either Sigma-Aldrich or Thermo 
Fisher Scientific, Inc. (Waltham, MA). 
5.2.2 Sample preparation and instrumental techniques 
NMR sample preparation. 31P NMR samples contained 670 µM each enzyme and 
substrate in 50 mM MES sodium, pH 6.0, in 10 % v/v D2O. Samples were prepared by first 
dialyzing equal amounts of the enzyme and substrate strands in buffer (treated with Chelex® 
100 beads) containing 50 mM MES sodium, pH 6.0, against the same buffer, followed by 
lyophilization. The samples were then re-dissolved in 10 % D2O and denatured at 55 °C in a 
water bath followed by gradual cooling to room temperature to ensure complete 
hybridization.  
Analysis by 31P NMR. 31P NMR spectra were collected at 242.8 MHz on a Varian 
UNITY INOVA spectrometer with a 5 mm AutoTuneX probe. Temperature was held 
constant at 25 °C and samples were referenced using an internal coaxial tube containing 5 % 
trimethyl phosphate (3.70 ppm) in D2O. Pb2+ titrations were carried out at room temperature 
by removing the sample from the NMR tube and adding aliquots of either a 100 mM or 200 
mM Pb(NO3)2 aqueous solution as appropriate, with constant magnetic stirring. Samples 
were chloride-free to minimize precipitation and were allowed to equilibrate for ten minutes 
before the start of acquisition. 
Kinetic assays under NMR or UV-Vis (concentrated) conditions. Enzyme and 
substrate at 670 µM each in 50 mM MES sodium, pH 6.0, were heated to >55 °C and cooled 
to room temperature on the bench. A 2.5 µL aliquot was removed prior to metal ion addition 
and added to stop solution (7 M urea, 40% v/v formamide, 12% w/v Ficoll, 30 mM EDTA, 
100 mM Bis-tris, and 0.05 % each bromophenol blue and xylene cyanol). Aliquots were 
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removed at appropriate intervals after metal ion addition and added to stop solution.  The 
cleaved and uncleaved bands were separated by 20% denaturing PAGE. Gels were stained 
with ethidium bromide followed by imaging on a Fuji FLA-3000 phosphorimager, Fujifilm 
Corp. Gels were interpreted qualitatively not quantitatively. 
UV-Vis spectrophotometric analysis. Initial UV-Vis spectra were collected on an 
Agilent 8453 spectrophotometer, Agilent Technologies, Inc. (Santa Clara, CA), whereas  
higher resolution spectra were collected on a Cary 5000 UV-Vis-NIR spectrophotometer, 
Agilent Technologies, Inc. Samples were prepared as appropriate and annealed by heating to 
ca. 90 °C for several minutes followed by gradual cooling to room temperature, except in the 
case of small molecule models which were not annealed. 
Determination of M2+ affinity for the reaction products. To gain a semi-quantitative 
measure of the affinity differences between different metal ions and different sequences, 
reactions were performed at known concentrations and excess M2+ was removed by desalting 
on a Sep Pak® cartridge (Waters Corporation, Milford, MA). Samples were then lyophilized 
to dryness, re-dissolved, and the DNA was quantified by UV-Vis. Concentration of Pb2+, 
Zn2+, or Mg2+ in samples was determined by inductively coupled plasma optical emission 
spectroscopy (ICP-OES) using a PE Optima 2000DV OES (PerkinElmer, Inc., Waltham, 
MA) by the School of Chemical Sciences Microanalysis Laboratory at the University of 
Illinois at Urbana-Champaign. 
Mass spectrometric analysis of reaction products. Samples containing 10 µL 17E and 
17SrAPS (or another appropriate substrate strand) at 670 µM in 50 mM MES sodium, pH 6, 
were heated to ca. 90 °C followed by cooling to room temperature on the bench. The 
appropriate M2+ stock solution was added and the reaction was allowed to proceed (20 
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minutes for Pb2+, 1 hr for Zn2+, and 4 hr for Mg2+, with the longer reaction times allowed for 
lower activity). Additional samples were allowed to react overnight and all were followed by 
rapid dilution of a 2.5 μL aliquot to 1000 µL and immediate desalting on a Sep-Pak® 
cartridge (Waters Corporation, Milford, MA) and subsequent lyophilization.   Samples were 
dissolved in water, the concentration was confirmed by UV-Vis, and adjusted to 100 pmol/10 
µL, and mass spectrometric data was collected. To prevent further degradation by M2+ 
remaining after the Sep-Pak® step, samples were refrozen following redissolution and 
determination of concentration. Samples were optionally further desalted by Zip Tip® 
(Millipore, Billerica, MA). Matrix assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) was performed on an Applied Biosystems Voyager-DE 
(AB SCIEX, Foster City, CA) by the School of Chemical Sciences Mass Spectrometry 
Laboratory at the University of Illinois at Urbana-Champaign. 
5.3 Results 
5.3.1 Monitoring the cleavage reaction using instrumental techniques 
The original NMR sample in which the color was first noted contained 670 µM 17E 
and 17SrAPS as well as 5 eq. Pb2+. It was suspected that the appearance of color, arising 
from charge transfer between Pb2+ and sulfur, tracked roughly with activity as the color did 
not appear immediately upon mixing Pb2+ into the NMR sample, but rather arose over the 
course of the ca. 3 hr acquisition time. No color was noted with any other phosphorothioate 
modifications nor was color noted with 17SAPS, containing a deoxyriboadenosine at the 
cleavage site leading to an inactive enzyme. In order to confirm that the generation of color 
tracked roughly with cleavage activity, an activity assay under the same buffer and 
concentration conditions as the NMR experiment was performed with visual monitoring of 
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the color and analysis of the products via denaturing PAGE with ethidium bromide staining 
(Figure 5.4). It was noted that the color began to appear visually within five minutes and 
reached a maximum around 20 minutes. Most of the substrate strand was cleaved during the 
20 minute reaction. 
 
Figure 5.4 Activity assay of 17E with either 17S or 17SrAPS as the substrate strand. The 
concentration of enzyme and substrate were both 670 µM and 5 eq. Pb2+ were added. 
Aliquots were quenched at the indicated time points. Products were separated by 
polyacrylamide gel electrophoresis, stained with ethidium bromide, and imaged. No color 
was noted with 17S, though a distinct red color appeared in the 17SrAPS sample within 
several minutes. 
Noting that color generation tracked roughly with cleavage activity, further study was 
conducted via UV-Vis analysis, providing a convenient spectroscopic handle to monitor the 
cleavage reaction, as well as the generation of color. As the original NMR sample had such a 
high absorbance across a span of several hundred nanometers in the visible region, a ten-fold 
reduction to 67 µM each 17SrAPS and 17E was used for UV-Vis characterization. As shown 
in Figure 5.5, a shoulder was present at 360 nm and a smaller shoulder at 580 nm. These 
signals started growing in immediately upon addition of 5 eq. Pb2+ and increased over the 
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course of 1 hour, slowing down towards the end. It should be noted that the 260 nm peak 
used to characterize DNA concentration is very far off scale.  
 
Figure 5.5 UV-Vis spectra of 67 µM each 17SrAPS and 17E in 50 mM MES sodium, pH 6, 
upon addition of 5 eq. Pb2+. Addition of Pb2+ took place 3 minutes after the start of 
acquisition and spectra were collected every minute for one hour. 
In order to examine whether the red species can be generated at even lower 
concentrations, a titration was performed at 6.7 µM each 17SrAPS and 17E, still with 5 eq. 
Pb2+. 
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Figure 5.6 UV-Vis spectra of 6.7 µM 17SrAPS and 17E in 50 mM MES sodium, pH 6, upon 
addition of 5 eq. Pb2+. The insets show the 260 nm and 360 nm peaks. 
As shown in Figure 5.6 only small increases at 260 nm and 360 nm were observed. At 
67 µM it is not possible to examine the 260 nm peak due to the high concentration of DNA, 
though at 6.7 µM it is possible and a small increase is noted. Comparison of the 360 nm peak 
reveals a relatively intense signal at 67 µM, but minimal increase at 6.7 µM. An increase to 
10 eq. Pb2+ resulted in a larger increase at both 260 nm and 360 nm, though still much less 
than would be expected if based purely on a ten-fold lower concentration of DNA compared 
to the data at 67 µM. As activity does not decrease at lower concentrations (activity assays 
are normally performed in the low nanomolar range),10 the generation of a red species 
appears to be very concentration dependent. 
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Figure 5.7 UV-Vis spectra of 670 µM 17E and 17SrAPS in 50 mM MES sodium pH 6 upon 
addition of 5 eq. Pb2+ with respect to 17SrAPS. 
Though characterization by UV-Vis at 670 µM each 17SrAPS and 17E is not easy 
due to the very intense background signal of DNA, a titration was performed with addition of 
5 eq. Pb2+ to further support the suspected concentration dependence. Three initial spectra 
were collected, followed by Pb2+ addition and subsequent spectra were taken once per minute 
for a total of 60 minutes. As seen in Figure 5.7 the absorbance increased very rapidly 
reaching the instrument maximum of 10 a.u. at 360 nm within seven minutes after Pb2+ 
addition. This absorbance does not scale linearly with concentration as seen between 67 µM 
and 6.7 µM. 
As the 8-17 DNAzyme is capable of performing multiple turnovers, the concentration 
of 17SrAPS was held at 67 µM and the equivalents of Pb2+ were held at 5 relative to 
17SrAPS while varying the equivalents of enzyme. 
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Figure 5.8 67 µM 17SrAPS + 5 eq Pb2+ with varying equivalents of 17E 
 
As shown in Figure 5.8 maximum signal was obtained with 0.5 eq. 17E followed by 
0.1 eq. 17E, with a 1:1 ratio 17SrAPS:17E producing the lowest overall signal. This data 
indicates that a certain amount of 17E is necessary in order to cleave the substrate (as 
expected), though 17E itself may bind Pb2+ effectively reducing the amount of Pb2+ available 
for binding to the cleaved substrate. 
In order to investigate whether the phosphorothioate-modified substrate strand 
behaves in a similar manner to the unmodified substrate strand, mutations with G1.1rN at the 
cleavage site (all with phosphorothioate modifications at the cleavage site) were tested as 
shown in Figure 5.9. In the native system purines cleave faster pyrimidines10 and the same 
general trend was observed here. 
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Figure 5.9 Absorbance at 360 nm vs. time for substrate sequences with varying 
ribonucleotides at the cleavage site (G1.1rN), all at 67 µM with 67 µM 17E in 50 mM MES 
sodium, pH 6. Metal ion addition (5 eq. Pb2+) took place three minutes after the start of 
acquisition. 
The native system is substantially more active at pH 7 than pH 6; in fact activity 
assays with Pb2+ are usually performed at pH 6 to get a reliable estimation of the observed 
rate. To test whether this pH dependence carries over to the modified substrate, 17SrAPS was 
tested at different pH values. The solubility of Pb2+ is also enhanced at lower pH which is 
beneficial when higher DNA concentrations (approaching millimolar) are used. 
Representative traces comparing pH 7 and pH 6 are shown in Figure 5.10, which show that 
the increase at 360 nm is significantly faster at pH 7 where the DNAzyme is also more 
active. These results support the assumption that a phosphorothioate modification is an 
isostructural mutation, resulting in no significant changes to reactivity, and also that 
formation of the red color tracks roughly with activity and can be used as a spectroscopic 
handle under these conditions. 
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Figure 5.10 Absorbance at 360 nm vs. time for 67 µM each 17SrAPS and 17E in the 
specified buffer upon addition of 5 eq. Pb2+. All samples contained 50 mM Na+ and Pb2+ 
addition took place three minutes after the start of acquisition. 
5.3.2 Characterization of reaction products 
The cleavage products of the unmodified 8-17 DNAzyme substrate are well 
characterized.47 Upon interaction with Pb2+, Mg2+, Zn2+, or other divalent metal ions the 
substrate strand is cleaved into 5′ and 3′ fragments. The 5′ fragment has a terminal 2′,3′-
cyclic phosphate (cyclic Product 1). The 3′ fragment has a terminal 5′-OH (Product 2). In the 
presence of Pb2+ only, the cyclic phosphate product is hydrolyzed to form either a 2′ or 3′ 
phosphate (Product 1). These products and more are noted in Figure 5.11. Addition of a non-
bridging sulfur increases the number of possible products, though the cleavage mechanism is 
not expected to change, as noted for the hammerhead ribozyme.48  
In order to provide support for an unaltered cleavage mechanism upon 
phosphorothioate modification of the substrate , 17SrAPS was cleaved in the presence of an 
equal concentration of 17E and a fivefold excess of Pb2+, allowed to react for ca. 20 minutes, 
quenched by addition of excess EDTA, and desalted by Sep-Pak®. The products were then 
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separated by PAGE, recovered from the gel, desalted by Sep-Pak® and an aliquot was 
analyzed by MALDI-TOF MS. The remainder of each sample was saved for analysis by UV-
Vis or other technique. The fastest migrating gel band was expected to correspond to cyclic 
fragments as noted for the unmodified substrate and the slower migrating product band was 
expected to correspond to the 3′ product.47 
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Figure 5.11 Routes to formation of various products from 17SrAPS via Pb2+-induced 
cleavage. 
As noted in Figure 5.12, MS analysis of the lower gel band resulted in two main 
peaks at 3050 Da and 3068 Da. The expected mass of cP3 is 3064 Da, which agrees fairly 
well with the measured value of 3068 Da, within the range of error for the instrument used. It 
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should be noted that separate experiments have been in better agreement with the expected 
masses. It is possible that the 3068 Da peak corresponds to P1 as well as cP3, as these 
products are not easily distinguished based on mass alone. It is unlikely that the 3068 Da 
peak corresponds solely to P1, as complete desulfurization during the cleavage reaction or 
shortly thereafter is not expected. 
        
Figure 5.12. MS data corresponding to the lower gel band and the higher gel band, left to 
right. Peaks for the lower gel band, 3050.16 Da and 3068.24 Da, are assigned to Product 1 
and cyclic Product 3/Product 1, respectively. Peaks for the higher gel band, 3141.61 Da and 
1570.6 Da are assigned to Product 2, singly and doubly charged. 
Several pathways, however, may involve desulfurization, which is supported by the 
MS results. It has been noted that the rate of phosphorothioate desulfurization (forming a 
backbone phosphate in place of the phosphorothioate) is roughly 1x10-6/min which is close to 
the background hydrolysis of RNA.53,36  As stock solutions are dissolved in Chelexed buffer 
and stored at -20°C, the amount of desulfurization before the start of the reaction should be 
minimal. Though cP1 could be produced via this route, desulfurization of the starting 
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material (17SrAPS) followed by cleavage as noted in Figure 5.11, it is unlikely to contribute 
significantly. Desulfurization is therefore more likely to occur after formation of cP3. Ora et 
al. studied hydrolysis and desulfurization of 2′,3′-cUMPS over a wide pH range and found 
that at high pH (>9), hydrolysis was the most likely pathway, whereas at neutral and acidic 
pH desulfurization to 2′,3′-cUMP competes with hydrolysis. It was also noted that at pH >5, 
desulfurization is 5-fold faster for Rp than Sp and that depyrimidination is a competing 
reaction at neutral pH.54 The MS data shown here do not provide support for 
depyrimidination, though desulfurization is supported. It should be noted that there is a limit 
to the amount of desulfurization, as the red color remains for months in a sample at room 
temperature. Production of the color by a cleaved fragment (small molecule) can also be 
ruled out, as the color migrates with the DNA band on a PD-10 desalting/size exclusion 
column, is not removed by dialysis across a 2,000 molecular weight cutoff membrane, and 
sticks to a Sep-Pak® column. 
Further support for assignment of the 3050 Da peak to cP1 is provided by hydrolysis. 
For small molecules, hydrolysis of a cyclic phosphorothioate may be accomplished in 2 N 
KOH, as it is very stable in 0.1 N HCl, unlike cyclic phosphates.55 Gel purified fragments 
corresponding to the 5′ products (inseparable by gel) as confirmed by MS were hydrolyzed in 
2 N KOH, neutralized, desalted, and analyzed again by MS. The peak assigned to cP3 (or P1 
as their mass-to-charge ratios are very close) was still present, though the peak corresponding 
to cP1 disappeared. It is possible that cP3 was successfully and completely hydrolyzed, 
though no peak at 3082 Da, corresponding to P3, was noted and complete desulfurization 
would be unlikely under these conditions. The presence of DNA may interfere with the 
hydrolysis of cP3, lending enhanced stability. 
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In order to confirm that cP3 is indeed responsible for color generation, the fragments 
were dissolved in 50 mM MES sodium, pH 6, and the UV-Vis spectrum was monitored upon 
Pb2+ addition. Despite the inability to separate cP3 from cP1 or P1 these products are not 
known to generate color (cP1 and P1 are the products of the wild-type enzyme and no color 
has ever been noted for 8-17, unpublished results), though they may bind to Pb2+, reducing 
the overall signal intensity. The absorbance at 360 nm increased upon addition of Pb2+ to 
either cP3 alone or in combination with 17E. No increase was seen for P2 with 17E and Pb2+ 
as expected; P2 has a 5′-OH terminus and is therefore unlikely to generate any charge 
transfer bands. 
 
Figure 5.13. Absorbance at 360 nm vs. time for cP3 (with and without 17E) and P2 (with 
17E) at 67 µM each DNA strand, plus 5 eq. Pb2+ added three minutes after the start of 
acquisition. 
5.3.3 Comparison to small molecule model complexes 
As the presence of many DNA nucleotides not directly involved in charge transfer 
complicates study of this system, it was desirable to use small molecule models to provide 
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further support for the proposed interacting species. Multiple works have investigated the 
synthesis and behavior of small molecule phosphorothioates,56,55,57,53,54,58-63 two with Pb2+ in 
particular.64,65 Interactions of Pb2+ with small molecule models MeOPS2-, UMPS2-, and 
AMPS2- were investigated and it was discovered that stability is determined by thiophosphate 
basicity. Chelate formation with the adenine N7 was not observed and Pb2+ was coordinated 
to the deprotonated thiophosphate.59,64,66 The same effect is supported in this system as the 
colored species is generated regardless of the ribonucleotide at the cleavage site, and the rate 
of increase at 360 nm correlates with the known cleavage rate of rN. It is also noted that 
affinity of Pb2+ for a thiophosphate diester bridge is much higher than for any other groups 
on DNA, and equal distribution between phosphates and phosphorothioates will only occur at 
a ratio of 1:100 thiophosphate to phosphate.64 Interestingly, Pb2+ prefers to bind to sulfur in 
UMPS2-, but when the phosphorothioate is bridging in a dinucleotide, oxygen is preferred 
instead with no evidence of coordination to sulfur.65 This explains the absence of color if a 
non-cleavable analog of 17SrAPS, 17DSAPS, is used.  
Comparison was first made to adenosine 5′-O-monophosporothioate (AMPS2-) shown 
in Figure 5.14. Pb2+ interaction is expected to occur with the thiophosphate group and not the 
base,64  resulting in the UV-Vis spectrum shown in Figure 5.15. 
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Figure 5.14 Structure of adenosine 5′-O-monophosphorothioate (AMPS2-), also known as 
adenosine 5′-O-thiomonophosphate. Cations are removed for clarity. 
 
Figure 5.15 UV-Vis spectra of 67 µM AMPS in 50 mM MES sodium, pH 6, upon addition 
of 5 eq. Pb2+. The inset shows an enlarged view around 260 nm indicating rapid spectral 
change and subsequent stabilization. 
A significant absorbance increase was noted at ca. 260 nm and a very minor increase 
was noted at ~290 nm. The spectral change also took place rapidly in comparison to that seen 
for the red species, taking place within less than one minute, the time in between scans in 
which Pb2+ was added. Stabilization of the signal also took place within the same period 
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indicating very rapid association and equilibration. The spectral change noted above has 
markedly different characteristics from that of the red species and is unlikely to contribute 
significantly to the spectrum seen for 17SrAPS + 17E, even if a significant quantity of P3 
was present, which is not supported by MS. Other small molecules with greater similarity to 
the proposed species were investigated, including 3′,5′-cAMPS. Both chiral forms are shown 
below in Figure 5.16. A titration of Pb2+ into Sp-3′,5′-cAMPS while monitoring the UV-Vis 
spectrum was carried out analogous to AMPS and the resulting spectra are shown in Figure 
5.17. 
 
 
Figure 5.16 Rp-Adenosine 3′,5′-cyclic monophosphorothioate (Rp-3′,5′-cAMPS) and Sp- 
Adenosine  3′,5′-cyclic monophosphorothioate (Sp-3′,5′-cAMPS), respectively. Cations are 
removed for clarity. 
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Figure 5.17 UV-Vis spectra of 67 µM Sp-3′,5′-cAMPS in 50 mM MES sodium, pH 6, upon 
addition of 5 eq. Pb2+. The inset shows an enlarged view around 260 nm indicating a slow 
and minor (relative to AMPS) spectral change. 
In comparison to AMPS, minimal change was seen at 260 nm and at 290 nm. The 
spectrum was monitored for 1 hour and no significant change took place. Though this small 
molecule model is a cyclic phosphorothioate, it is a 3′,5′-cyclic phosphorothioate, not a 2′,3′-
cyclic phosphorothioate. Such a species is not expected to occur in this system due to the 
stability of the DNA backbone. Fortunately, a 2′,3′-cyclic phosphorothioate is commercially 
available and is shown in Figure 5.18. 
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Figure 5.18 Rp-Adenosine 2′,3′-cyclic monophosphorothioate (Rp-2′,3′-cAMPS) and Sp- 
Adenosine  2′,3′-cyclic monophosphorothioate (Sp-2′,3′-cAMPS), respectively. Cations are 
removed for clarity. 
 
 
Figure 5.19 UV-Vis spectra of 67 µM Rp-2′,3′-cAMPS in 50 mM MES sodium, pH 6, upon 
addition of 5 eq. Pb2+. 
Addition of 5 eq. Pb2+ at three minutes resulted in an immediate increase, continuing 
steadily over the course of the 1 hour data collection. Sp-2′,3′-cAMPS was also tested and 
gave a similar spectrum. As this small molecule model corresponds to cP3, a 2′,3′-cyclic 
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phosphorothioate, it is very likely that cP3 is responsible for the red color. Importantly, the 
observed 2′,3′-cAMPS spectrum generally matches that seen with 17SrAPS. Like with 
AMPS, a signal increase takes place at 260 nm, though unlike AMPS (and like 17SrAPS), 
the signal increase takes place over the course of one hour rather than in one minute. Finally, 
a range of Pb2+ equivalents vs. Rp-2′,3′-cAMPS were tested and it was noted that more Pb2+ 
equivalents are necessary with this small molecule model than with 17SrAPS and 17E at the 
same concentration. In addition, the signal increase with both 5 eq. and 10 eq. Pb2+ had not 
leveled off by 1 hour, unlike that seen with 17SrAPS and 17E. Perhaps the presence of the 
enzyme strand leads to a faster signal increase when compared to 2′,3′-cAMPS as the enzyme 
strand may position Pb2+ for binding to the 2′,3′ cyclic phosphorothioate following the 
substrate cleavage reaction. 
 
Figure 5.20 Absorbance at 360 nm vs. time for of 67 µM Rp-2′,3′-cAMPS in 50 mM MES 
sodium, pH 6, upon addition of varying eq. Pb2+. 
 
121 
 
5.3.4 Effects of the phosphorodithioate modification 
The red color seen here is ascribed to Pb2+-sulfur charge transfer. It was desired to 
increase the amount of sulfur available for binding in order to increase the signal output. 
Work has been undertaken on synthesis and interactions of dithiophosphates, where both 
non-bridging oxygen atoms are substituted with sulfur.67,68 This particular mutation removes 
the chirality generated when a single non-bridging oxygen is replaced by replacing both non-
bridging oxygen atoms. This modification was employed in the synthesis of 17SrAPS2, 
forming a phosphorodithioate in place of the phosphorothioate modification investigated thus 
far. A titration was performed analogous to 17SrAPS as shown in Figure 5.21. 
 
Figure 5.21 UV-Vis spectra of 67 µM each 17E and 17SrAPS2 plus 5 eq. Pb2+. 
As expected, the peak at 360 nM is roughly double the intensity of 17SrAPS under 
the same conditions and the general shape of the spectrum remains unchanged. This provides 
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support for additional Pb2+ binding due to an effective doubling of the available sulfur 
concentration. 
5.3.5 Effects of chelation 
In order to show that the red color is generated from a soluble species rather than a 
suspended small molecule complex, a non-selective chelator of Pb2+, 
ethylenediaminetetraacetic acid (EDTA), was added at two different time points, either 5 min 
or 35 min into the reaction. EDTA is commonly used to quench activity assays immediately 
upon addition. Addition of EDTA should remove Pb2+ bound to any species with lower 
affinity as well as quench the cleavage reaction catalyzed by 17E. As shown in Figure 5.22, 
regardless of time of addition, the signal at 360 nm disappeared within several minutes of 
adding 1000 eq. EDTA (vs. 5 eq. Pb2+), providing strong support for an aqueous species 
generated from coordination of Pb2+. As the signal did not disappear immediately, Pb2+ has a 
reasonably high affinity for the cyclic phosphorothioate. The red color also survives desalting 
on a Sep-Pak® column. 
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Figure 5.22 Absorbance at 360 nm vs. time for addition of EDTA at either 5 min or 35 min. 
Pb2+ in the amount of 5 eq. was added three min after the start of data collection. 
5.3.6 Binding strength as indicated by ICP 
The red species survives desalting on a Sep-Pak® C18 column, allowing removal of 
excess M2+. ICP analysis was performed on the DNA recovered from Sep-Pak® desalting and 
compared to the DNA concentration as determined by the UV-Vis absorbance at 260 nm 
(concentration of 17E plus products). As shown in Table 5.1, 0.5 eq. Pb2+ remained after 
desalting when the substrate was 17S. Mutation to 17SrAPS resulted in an increase to 0.76 
eq., and modification to 17SrAPS resulted in a ratio of 1.14, indicating an increase in affinity 
for each sulfur added. If the ratio for 17S is taken as a baseline or zero point, then adding two 
sulfurs instead of one results in twice as much Pb2+ binding to the DNA compared with one 
sulfur. More specifically, the mutation from a phosphate to phosphorothioate results in 0.28 
eq. additional Pb2+ binding to the DNA, whereas modification to a phosphorodithioate results 
in 0.66 eq. additional Pb2+, or roughly twice the increase as a phosphorothioate modification. 
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Table 5.1 Ratio of M2+:DNA as determined by ICP after desalting by Sep-Pak® 
 17S 17SrAPS 17SrAPS2 
Pb2+:DNA 0.48 0.76 1.14 
 
In comparison, the ratio of Mg2+:DNA for 17SrAPS was 0.03. All reactions with Pb2+ listed 
in Table 5.1 were run for 20 minutes. Incubation overnight resulted in an unchanged value 
for 17S, though a small decrease to 0.67 for 17SrAPS occurred, perhaps due to additional 
desulfurization. 
5.3.7 Metal ion specificity of the reaction and stability of the resulting species 
Addition of either Zn2+ or Mg2+ to 17SrAPS + 17E did not result in a color change, 
though the DNAzyme is known to be active with both, and a cyclic phosphorothioate was 
generated as confirmed by MS. As with Pb2+ the cleavage mechanism is not expected to 
change from wild type and MS data supports this conclusion. As the 8-17 DNAzyme is 
minimally active with other M2+ that are thiophilic, the small molecule model 2′,3′-cAMPS 
was used to examine interaction. Addition of Cd2+ resulted in no significant change in signal 
at either 260 nm or 360 nm. On the other hand, addition of Hg2+ resulted in significant 
increases at both 260 nm and 360 nm as shown in Figure 5.23. 
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Figure 5.23 UV-Vis spectra of 67 µM Rp-2′,3′-cAMPS in 50 mM MES sodium, pH 6, upon 
addition of 10 eq. Hg2+. 
5.3.8 Extension to other DNAzyme systems 
To check the generality of this system one other DNAzyme was used. The 10-23 
DNAzyme, which has affinity for Mg2+ (the target in the initial selection) as well as Pb2+ was 
cleaved directly in the presence of Pb2+ and a spectral change analogous to the 17E system 
and the 2′,3′-cAMPS model complex resulted as shown in Figure 5.24.  
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Figure 5.24 UV-Vis spectra of 67 µM each 10-23SrAPS and 10-23E with addition of 5 eq. 
Pb2+. 
5.4 Conclusions 
A novel red Pb2+-DNA species was discovered and thoroughly characterized 
demonstrating that the cleavage mechanism of the 8-17 DNAzyme remains unchanged upon 
mutation of a non-bridging oxygen at the cleavage site to sulfur. One of the resulting 
cleavage products, a 2′,3′-cyclic phosphorothioate, is capable of binding Pb2+ and upon doing 
so produces a red color in a concentration-dependent manner. Through the use of small 
molecule models it has been shown that a 2′,3′-cyclic phosphorothioate does change color 
upon binding to Pb2+ or Hg2+. Association takes place slowly in comparison to a pendant 
phosphorothioate and the color can be removed by addition of a chelator. The red color of the 
Pb2+-DNA species persists at room temperature for several months and such a color change 
was extended to the 10-23 DNAzyme. Pb2+ shows remarkable preference for a 2′,3′-cyclic 
phosphorothioate over a 3′,5′-cyclic phosphorothioate in terms of color generation, eluding to 
unique properties of 2′,3′-cyclic phosphorothioates. This unique behavior will enable 
detection of 2′,3′-cyclic phosphorothioates in other systems where analysis by mass 
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spectrometry or other techniques is cumbersome as well as enhancing understanding of the 
conditions necessary for Pb2+-sulfur charge transfer in the visible region. 
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